Other disorders of nervous system

G6_NEUROOTH

nervous system disease: A non-neoplastic or neoplastic disorder that affects the brain, spinal cord, or peripheral nerves.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G98, G99* Cause of death: ICD-10 — G98, G99* 2 out of 7 registries used, show all original rules.	2682
4. Check minimum number of events None	2682
5. Include endpoints None	2682
6. Filter based on genotype QC (FinnGen only)	2592

Control definitions (FinnGen only)

Control exclude: G6_OTHNEU

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	G6_NEUROOTH
CONTROL_EXCLUDE	G6_OTHNEU
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G98\|G99
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G98\|G99
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other disorders of nervous system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	13637	6281	7307
Only index persons	12774	5937	6837
Unadjusted period prevalence (%)
Whole population	0.19	0.18	0.20
Only index persons	0.24	0.22	0.26
Median age at first event (years)
Whole population	58.90	59.38	58.44
Only index persons	58.38	58.76	58.05

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2592	1298	1294
Unadjusted period prevalence (%)	0.53	0.46	0.59
Median age at first event (years)	59.85	58.19	61.51

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2682: Matched controls
26820

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

5.2

320.2

875

2299

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

15.0

318.4

292

216

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

23.4

307.7

647

359

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

9.7

307.7

670

892

ABC60

NOMESCO Finland

Decompression of cervical spinal cord

205.0

307.7

487

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

5709.4

307.7

830

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

13.8

307.7

614

566

M47.9

ICD-10 Finland

Spondylosis, unspecified

11.6

307.7

355

349

N03AX12

ATC

[U] gabapentin; oral

5.8

307.7

1037

2638

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

54.8

307.7

460

101

M48.0

ICD-10 Finland

Spinal stenosis

11.5

307.7

1239

1870

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

19.5

307.7

805

578

N03AX16

ATC

[U] pregabalin

5.9

307.7

1377

4048

NAG41

NOMESCO Finland

Anterior fusion of cervical spine with fixation

58.7

307.7

186

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

1070.5

307.7

370

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

28.9

307.7

570

248

G99.2*M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

2043.0

307.7

620

G99.2

ICD-10 Finland

Myelopathy in diseases classified elsewhere

834.1

307.7

362

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

6.4

307.7

715

1440

G99.2*M47.9

ICD-10 Finland

Myelopathy in spondylosis

1145.2

307.7

392

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

21.3

306.1

234

120

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

16.8

287.2

246

160

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

5.5

271.4

621

1385

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

6.4

258.9

481

881

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

7.2

254.7

415

664

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.6

239.9

722

2004

ABC50

NOMESCO Finland

Decopression of cervical spinal canal and nerve roots

78.4

237.4

127

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

9.3

225.8

285

337

N02AX02

ATC

tramadol; systemic, rectal

3.6

221.7

1686

8611

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

19.5

220.6

174

M03BX01

ATC

baclofen; systemic

13.2

209.1

204

166

WX408

NOMESCO Finland

General anesthesy, balanced

3.4

201.9

1123

4671

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

7.2

192.8

306

472

N06AX21

ATC

duloxetine; oral

4.2

186.4

595

1700

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

18.1

182.7

149

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

11.5

179.2

191

178

G99.2*M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

1814.7

170.6

164

M50.3

ICD-10 Finland

Other cervical disc degeneration

9.2

168.2

211

246

L01

ICPC

Neck symptom/complaint

3.6

166.5

684

2312

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

16.2

165.1

142

N02BF01

ATC

gabapentin; oral

4.5

163.3

451

1148

T91.3

ICD-10 Finland

Sequelae of injury of spinal cord

83.5

152.6

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.2

139.0

683

2553

N02BF02

ATC

pregabalin; oral

4.9

137.5

330

746

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

4.1

133.4

419

1166

M54.2

ICD-10 Finland

Cervicalgia

4.2

132.9

400

1079

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

19.4

131.4

103

N06AA09

ATC

amitriptyline; systemic

3.8

129.5

459

1389

NA1AD

NOMESCO Finland

Cervical spine CT examination

5.4

129.4

271

544

XKD06

NOMESCO Finland

Physiologic investigation of micturition

6.6

128.4

215

348

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

6.7

127.5

210

334

AA1AD

NOMESCO Finland

CT of head and brain

2.8

127.2

922

4247

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

6.0

126.4

237

429

M54.4

ICD-10 Finland

Lumbago with sciatica

3.0

125.5

710

2861

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.9

122.2

196

303

M54.1

ICD-10 Finland

Radiculopathy

5.6

121.8

247

481

NAG42

NOMESCO Finland

Posterior fusion of cervical spine with or without fixation

41.1

118.9

G56.0

ICD-10 Finland

Carpal tunnel syndrome

3.1

114.9

578

2168

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

11.7

112.8

117

104

XKC03

NOMESCO Finland

Water cystometry

6.2

110.8

197

338

L28

ICPC

Limited function/disability (L)

2.9

110.2

667

2766

L86

ICPC

Back syndrome with radiating pain

4.3

108.8

306

780

G82.2

ICD-10 Finland

Paraplegia, unspecified

28.0

104.8

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

8.5

103.5

136

167

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.5

103.4

1001

5207

G98

ICD-10 Finland

Other disorders of nervous system, not elsewhere classified

527.8

103.3

102

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.9

102.5

332

937

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

7.3

101.3

152

218

G99.0*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy

+∞

100.7

M54.5

ICD-10 Finland

Low back pain

2.4

100.4

1161

6516

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

12.7

97.9

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

6.0

97.5

178

313

WX402

NOMESCO Finland

General anaesthesia

2.6

97.4

774

3656

L83

ICPC

Neck syndrome

12.1

96.6

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

6.5

96.2

163

266

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

93.6

1432

8967

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

13.5

93.2

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

12.7

91.8

M03BX02

ATC

tizanidine; oral

2.3

88.0

1867

13244

M53.1

ICD-10 Finland

Cervicobrachial syndrome

3.1

87.8

435

1599

M50.0

ICD-10 Finland

Cervical disc disorder with myelopathy

137.6

87.6

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.4

85.7

343

1109

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

85.3

328

1034

L03

ICPC

Low back symptom/complaint

2.3

84.3

891

4736

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.6

83.7

602

2686

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.6

82.9

581

2559

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

4.9

81.8

190

414

N02AA05

ATC

oxycodone; systemic

2.5

81.7

641

2977

ABC10

NOMESCO Finland

Microsurgical excision of cervical intervertebral disc displacement

23.2

81.3

G95.8

ICD-10 Finland

Other specified diseases of spinal cord

812.3

80.9

R20.2

ICD-10 Finland

Paraesthesia of skin

3.7

79.3

276

814

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

79.2

1431

9353

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

9.7

79.0

N03AX09

ATC

lamotrigine; oral

4.6

78.8

198

460

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

11.1

78.5

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

77.8

1314

8351

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

5.3

76.0

157

309

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

5.9

75.8

139

245

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.8

75.3

447

1804

E10.4

ICD-10 Finland

Type 1 diabetes mellitus, With neurological complications

13.5

75.2

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

14.6

74.3

SPAT1262

SPAT

Handing over of treatment supplies

2.4

73.1

622

2982

N06AX16

ATC

venlafaxine; oral

2.6

72.9

488

2090

M03BC01

ATC

orphenadrine (citrate); systemic

2.3

72.8

739

3822

M43.1

ICD-10 Finland

Spondylolisthesis

4.3

71.0

192

472

N03AE01

ATC

clonazepam; systemic

3.6

70.7

247

729

SPAT1229

SPAT

Assessment of need for aid

3.2

70.6

305

1029

G99.0*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic autonomic neuropathy

706.4

70.4

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.1

69.7

203

527

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

4.4

69.0

180

430

WX704

NOMESCO Finland

Intubation

3.1

68.6

318

1118

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

66.9

720

3797

XX2CT

NOMESCO Finland

Other injection with CT guidance

26.0

66.1

UKC02

NOMESCO Finland

Cystoscopy

2.4

65.1

565

2717

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

15.3

64.9

XKD03

NOMESCO Finland

Urethral pressure profilometry

5.7

64.9

124

227

N06AA10

ATC

nortriptyline; systemic

5.8

64.4

121

218

M79.6

ICD-10 Finland

Pain in limb

2.0

63.9

1223

7956

NAG53

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea

28.4

62.2

A01

ICPC

Pain general/multiple sites

2.9

62.0

327

1233

R52.2

ICD-10 Finland

Other chronic pain

4.2

61.6

171

428

M01AH05

ATC

etoricoxib; oral

2.0

61.6

1795

13423

N02BE01

ATC

paracetamol; systemic, rectal

3.3

61.4

2481

21212

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.1

61.3

286

1007

N18

ICPC

Paralysis/weakness

6.1

61.1

107

180

A02BC02

ATC

pantoprazole; systemic

2.1

61.0

1953

15078

SPAT1215

SPAT

Assessment of need for medical rehabilitation

4.0

60.6

177

460

S18

ICPC

Laceration/cut

1.9

60.4

1366

9346

ABB00

NOMESCO Finland

Excision of lesion of spinal canal

24.3

60.3

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

5.5

59.8

119

226

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

3.2

59.4

248

817

WX110

NOMESCO Finland

Infiltration anesthesia

2.1

58.0

1974

15418

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

298.3

57.5

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.4

57.4

154

NA1CM

NOMESCO Finland

Cervical spine extensive MRI examination with 3 Tesla magnet

20.3

57.4

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

57.3

904

5448

L89

ICD-10 Finland

Decubitus ulcer and pressure area

6.1

57.2

100

168

ABC63

NOMESCO Finland

Decompression of thoracic spinal cord

124.8

57.0

ZXE20

NOMESCO Finland

More than three and less than five hours

2.4

55.9

467

2197

C03CA01

ATC

furosemide; systemic

2.0

55.8

865

5174

ZXD05

NOMESCO Finland

Urgent procedure

2.0

55.4

879

5296

G992, M472,

ICD-10 Finland

+∞

55.4

X59

ICD-10 Finland

Exposure to unspecified factor

2.2

54.9

593

3101

J01MA02

ATC

ciprofloxacin; systemic

1.9

54.8

1141

7521

M48.9

ICD-10 Finland

Spondylopathy, unspecified

12.9

54.7

ABC66

NOMESCO Finland

Decompression of lumbal spinal channel

14.1

54.5

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

4.0

54.4

163

431

G992, M480,

ICD-10 Finland

+∞

54.3

R4120

NOMESCO Finland

Occupational therapy

3.1

54.3

246

850

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

54.0

900

5506

N81

ICPC

Injury nervous system other

23.3

53.8

J01FF01

ATC

clindamycin; systemic

2.0

53.3

834

4988

S97

ICPC

Chronic ulcer skin

3.1

53.2

239

821

NF1AA

NOMESCO Finland

Hip X-ray examination

2.7

53.2

315

1258

SPAT1263

SPAT

Sampling

1.9

52.8

1158

7737

R1250

NOMESCO Finland

Evaluation of functional capability

5.2

52.5

109

215

WX725

NOMESCO Finland

Noninvasive ventilation

3.2

52.3

216

706

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

8.3

52.2

ZXE10

NOMESCO Finland

More than one and less than three hours

1.9

52.0

1055

6865

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

10.8

51.6

ACC51

NOMESCO Finland

Release of median nerve

2.8

51.3

282

1083

SPAT1153

SPAT

Removal of sutures

1.9

51.2

958

6068

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

50.7

386

1737

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.1

50.7

229

789

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

50.6

688

3906

N06AX11

ATC

mirtazapine; oral

1.9

50.5

964

6138

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.9

49.4

796

4787

N31.8

ICD-10 Finland

Other neuromuscular dysfunction of bladder

15.1

48.6

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.1

48.3

213

723

R42

ICD-10 Finland

Dizziness and giddiness

2.0

47.0

638

3607

A02BC05

ATC

esomeprazole; systemic

1.8

47.0

1166

8007

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

46.9

328

1417

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

11.3

46.7

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

5.1

46.1

201

NAG65

NOMESCO Finland

Anterior and posterior fusion of lumbar spine

13.1

46.0

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

46.0

1152

7916

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

9.6

45.1

R33

ICD-10 Finland

Retention of urine

2.6

45.1

279

1135

M54.3

ICD-10 Finland

Sciatica

3.0

44.9

216

770

SPAT1216

SPAT

Assessment of functional ability

2.1

43.8

463

2380

A28

ICPC

Limited function/disability NOS

2.1

43.7

497

2628

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

43.6

372

1753

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

5.6

43.5

155

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.5

43.1

106

241

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

43.1

351

1621

M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

81.5

43.0

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.6

43.0

145

416

NA1DG

NOMESCO Finland

Cervical spine very extensive MRI examination with high intensity magnet

17.7

42.9

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.4

42.8

113

N05CF01

ATC

zopiclone; oral

1.8

42.7

913

5953

M01AB05

ATC

diclofenac; systemic, rectal

1.8

42.3

1829

14574

R51.80

ICD-10 Finland

Headache

2.2

42.0

417

2090

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

41.8

233

899

NA2AD

NOMESCO Finland

Thoracic spine CT examination

10.2

41.6

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.2

41.3

384

1873

R52.1

ICD-10 Finland

Chronic intractable pain

7.7

41.2

J01DB01

ATC

cefalexin; oral

2.0

41.2

2224

18914

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

8.4

40.7

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

40.6

224

859

M01AH02

ATC

rofecoxib; oral

2.2

40.1

405

2040

A10AB05

ATC

insulin aspart; parenteral

2.6

40.1

254

1044

G47.3

ICD-10 Finland

Sleep apnoea

1.9

40.1

700

4274

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

7.9

40.0

N30.0

ICD-10 Finland

Acute cystitis

2.1

40.0

432

2234

N02AC04

ATC

dextropropoxyphene; oral

3.5

39.9

139

407

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

39.9

340

1598

R53

ICD-10 Finland

Malaise and fatigue

1.9

39.8

626

3694

Z50.1

ICD-10 Finland

Other physical therapy

2.9

39.7

197

714

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

6.0

39.7

122

A06AD11

ATC

lactulose; oral

2.1

39.5

433

2250

A46

ICD-10 Finland

Erysipelas

2.1

39.3

451

2384

A02BC01

ATC

omeprazole; systemic

1.8

39.2

757

4762

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.1

39.2

411

2100

ABC53

NOMESCO Finland

Decompression of thoracic spinal canal and nerve roots

65.3

39.2

SPAT1301

SPAT

No procedures

1.8

38.9

841

5469

R4110

NOMESCO Finland

Physiotherapy

1.8

38.8

793

5073

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

3.1

38.8

172

585

G44.2

ICD-10 Finland

Tension-type headache

2.2

38.4

378

1883

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.6

38.2

238

970

R4110, ,

SPAT

2.4

38.0

289

1292

M03BC51

ATC

orphenadrine, combinations; systemic

1.8

37.9

768

4894

103

Kela drug reimbursment

Diabetes, insulin-treated

1.8

37.7

783

5025

M01AH01

ATC

celecoxib; oral

1.9

37.6

534

3041

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.3

37.5

238

J01MA12

ATC

levofloxacin; systemic

1.9

37.2

558

3233

A10AB01

ATC

insulin (human); parenteral

3.7

37.0

121

340

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.9

37.0

183

662

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

131.9

36.8

G83.4

ICD-10 Finland

Cauda equina syndrome

12.6

36.7

R52.9

ICD-10 Finland

Pain, unspecified

2.3

36.5

300

1386

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.6

36.5

235

972

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

36.5

928

6296

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

7.6

36.5

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.8

36.4

731

4636

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.1

36.3

381

1944

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.5

36.1

125

365

A10AB04

ATC

insulin lispro; parenteral

3.7

36.0

115

318

XKD00

NOMESCO Finland

Uroflowmetry

2.0

35.8

494

2780

N31.1

ICD-10 Finland

Reflex neuropathic bladder, not elsewhere classified

7.9

35.8

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

35.7

671

4170

H02AB06

ATC

prednisolone; systemic

1.7

35.5

1291

9611

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

35.4

488

2746

M01AB55

ATC

diclofenac, combinations; oral

2.5

35.4

228

944

A10AC01

ATC

insulin (human); parenteral

2.5

35.3

234

981

R13

ICD-10 Finland

Dysphagia

2.6

35.3

226

932

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

35.3

1016

7113

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.8

35.2

184

685

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

35.2

643

3958

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

3.3

35.2

137

431

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

35.2

300

1408

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

35.2

413

2196

ZZH40

NOMESCO Finland

Substitute of bone

6.6

34.9

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

7.7

34.8

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.0

34.3

431

2345

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.4

34.2

266

1200

R60.0

ICD-10 Finland

Localized oedema

2.1

34.0

361

1847

R06.0

ICD-10 Finland

Dyspnoea

1.8

34.0

738

4773

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

3.4

33.7

126

386

Z3226

NOMESCO Finland

Physiotherapist

1.9

33.5

517

3013

M43.0

ICD-10 Finland

Spondylolysis

4.5

33.5

190

H3603, E103,

ICD-10 Finland

7.2

33.5

A10AA01, ,

ATC

4.0

33.4

246

G992, M511,

ICD-10 Finland

+∞

33.4

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.5

33.0

224

949

N28

ICPC

Limited function/disability (N)

4.7

33.0

164

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.8

32.9

568

3427

M79.1

ICD-10 Finland

Myalgia

2.0

32.9

403

2171

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.1

32.9

339

1715

N07BC02

ATC

methadone; systemic

10.1

32.7

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

32.6

516

3030

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.3

32.6

274

1277

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.1

32.5

143

484

A10AA02, ,

ATC

3.5

32.5

112

326

M54.6

ICD-10 Finland

Pain in thoracic spine

2.5

32.3

223

953

G54.0

ICD-10 Finland

Brachial plexus disorders

3.9

32.3

257

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

32.2

782

5204

W19

ICD-10 Finland

Unspecified fall

2.2

32.1

283

1345

ACC53

NOMESCO Finland

Release of ulnar nerve

4.7

32.1

160

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

3.1

32.0

136

451

M25.5

ICD-10 Finland

Pain in joint

1.7

31.7

852

5822

A10AE04

ATC

insulin glargine; parenteral

2.2

31.6

297

1448

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

31.4

367

1942

A06AC01

ATC

ispaghula (psylla seeds); oral

1.7

31.4

703

4569

NAU20

NOMESCO Finland

Removal of internal fixation device from spine or neck

10.7

31.3

S14.0

ICD-10 Finland

Concussion and oedema of cervical spinal cord

53.6

31.3

L02

ICPC

Back symptom/complaint

2.2

31.3

278

1325

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

6.4

31.3

N29

ICPC

Neurological sympt/complt other

4.3

31.0

189

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

3.2

30.9

125

402

SPAT1254

SPAT

Administration of medicine

2.0

30.9

395

2157

TAB00

NOMESCO Finland

Lumbar puncture

3.0

30.7

139

478

R5110, ,

SPAT

2.5

30.7

208

881

L12

ICPC

Hand/finger symptom/complaint

1.9

30.7

442

2514

SPAT1231

SPAT

Assessment of adjustments needed in living environment

4.6

30.6

166

N05BA01

ATC

diazepam; systemic, rectal

2.0

30.3

371

1995

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

30.3

374

2017

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

+∞

30.3

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

30.2

220

962

M50

ICD-10 Finland

Cervical disc disorders

7.7

30.2

N06AB04

ATC

citalopram; systemic

1.8

30.1

558

3431

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

3.9

29.9

234

M01AE02

ATC

naproxen; oral, rectal

1.6

29.9

1467

11563

G04BD12

ATC

mirabegron; oral

2.0

29.8

348

1840

L17

ICPC

Foot/toe symptom/complaint

1.7

29.8

771

5199

G95.9

ICD-10 Finland

Disease of spinal cord, unspecified

156.8

29.7

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

7.2

29.7

L13

ICPC

Hip symptom/complaint

1.8

29.6

519

3137

A10AE05

ATC

insulin detemir; parenteral

2.6

29.5

173

683

UJF32

NOMESCO Finland

Coloscopy

1.7

29.2

723

4814

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

5.8

29.0

NAG52

NOMESCO Finland

Posterior or lateral fusion of thoracic spine with fixation, 2-3 vertebraea

66.7

28.9

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

28.9

231

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

28.8

330

1731

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

28.8

417

2371

NA1BG, ,

SPAT

4.5

28.8

162

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.3

28.7

233

1068

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

6.3

28.7

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

28.7

337

1784

M54

ICD-10 Finland

Dorsalgia

2.0

28.7

332

1749

M79.7

ICD-10 Finland

Fibromyalgia

3.3

28.6

109

338

TAB20

NOMESCO Finland

Epidural puncture

6.4

28.6

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.3

28.5

232

1065

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

28.4

187

781

ZXC95

NOMESCO Finland

Use of surgical navigator

5.1

28.3

117

L08

ICPC

Shoulder symptom/complaint

1.7

28.2

609

3903

M41.9

ICD-10 Finland

Scoliosis, unspecified

5.3

28.2

110

X58

ICD-10 Finland

Exposure to other specified factors

1.9

28.1

390

2186

R11

ICD-10 Finland

Nausea and vomiting

2.3

28.1

233

1078

G95.2

ICD-10 Finland

Cord compression, unspecified

78.5

27.8

J01EA01

ATC

trimethoprim; systemic

1.7

27.7

634

4124

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.4

27.7

102

310

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.4

27.4

200

875

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.8

27.4

140

515

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.9

27.2

364

2014

M50.8

ICD-10 Finland

Other cervical disc disorders

7.7

27.2

9212

FHL

Other posterior root decompression surgery (eg laminectomy, Gill)

8.8

27.2

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

6.9

27.2

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

27.1

662

4379

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

38.3

27.1

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

27.0

543

3407

M01AB51

ATC

indometacin, combinations; oral, rectal

3.4

26.9

286

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

32.2

26.8

J01DA01

ATC

[U] cefalexin

1.6

26.8

1585

12894

B01AC04

ATC

clopidogrel; oral

1.9

26.8

411

2378

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

7.1

26.7

H04AA01

ATC

glucagon; nasal, parenteral

4.2

26.7

172

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

26.7

364

2027

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

4.0

26.6

194

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.3

26.6

207

932

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.1

26.5

115

386

I10

ICD-10 Finland

Essential (primary) hypertension

1.6

26.5

1623

13291

N05BA04

ATC

oxazepam; oral

1.7

26.4

662

4405

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

26.4

245

1186

T90

ICPC

Diabetes non-insulin dependent

1.7

26.3

670

4474

ZXD35

NOMESCO Finland

Usual procedure

3.1

26.3

112

372

M01AX17

ATC

nimesulide; oral

1.7

26.2

666

4446

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

26.0

26.2

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

6.4

26.1

G99.0

ICD-10 Finland

Autonomic neuropathy in endocrine and metabolic diseases

+∞

26.1

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

5.0

26.1

114

N03AF01

ATC

carbamazepine; oral, rectal

2.6

26.1

158

634

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.3

26.0

307

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

3.4

25.9

283

G45.3

ICD-10 Finland

Amaurosis fugax

73.4

25.8

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

136.3

25.6

G82.5

ICD-10 Finland

Tetraplegia, unspecified

44.7

25.5

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

25.5

1329

10466

N05AH04

ATC

quetiapine; oral

1.8

25.3

437

2617

R35

ICD-10 Finland

Polyuria

2.3

25.3

207

951

A02BC03

ATC

lansoprazole; oral

1.6

25.3

770

5369

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

25.2

214

999

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.0

25.2

292

1536

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

7.7

25.1

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

8.9

25.1

M01AE51

ATC

ibuprofen, combinations; systemic

4.2

25.1

163

G95.0

ICD-10 Finland

Syringomyelia and syringobulbia

+∞

25.0

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

3.3

24.9

290

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

24.9

1074

8103

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

24.9

232

1125

N04BC05

ATC

pramipexole; oral

2.2

24.8

228

1099

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.3

24.8

296

K59.09

ICD-10 Finland

Constipation, unspecified

2.3

24.8

196

888

9211

FHL

Exploration or removal of diskusprolapse

3.5

24.5

258

B01AB05

ATC

enoxaparin; parenteral

1.6

24.4

833

5957

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.9

24.4

338

1889

M50.2

ICD-10 Finland

Other cervical disc displacement

29.4

24.1

SPAT1211

SPAT

Application of soft bandage

2.1

24.1

247

1242

WX002

NOMESCO Finland

Sedation and analgesia

1.7

23.9

524

3355

U04

ICPC

Incontinence urine

2.5

23.7

155

645

ABC21

NOMESCO Finland

Anterior decompression of cervical spine with insertion of interbody fixating implant

242.1

23.7

M99.3

ICD-10 Finland

Osseous stenosis of neural canal

8.7

23.7

R4180

NOMESCO Finland

Podiatric therapy

4.5

23.6

132

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.1

23.5

237

1183

M01AC06

ATC

meloxicam; systemic, rectal

1.5

23.5

964

7169

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

23.3

235

1173

SPAT1167

SPAT

Insertion of urinary catheter

3.1

23.3

101

339

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

23.3

177

788

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

9.7

23.2

T89

ICPC

Diabetes insulin dependent

2.7

23.2

123

461

L29

ICPC

Musculoskeletal sympt/complt other

2.1

23.1

239

1205

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

3.4

23.0

254

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.3

22.9

280

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

4.0

22.8

166

NF1DA

NOMESCO Finland

X-ray of hips

3.4

22.7

246

TAC99

NOMESCO Finland

Other blockade for chronic pain

6.3

22.7

H3600, E103,

ICD-10 Finland

5.2

22.7

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.0

22.7

258

1347

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

6.5

22.6

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

8.2

22.6

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

3.0

22.5

330

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

3.8

22.4

186

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.8

22.4

401

2421

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

22.4

394

2367

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

22.4

346

1999

J02AC01

ATC

fluconazole; systemic

1.5

22.4

926

6882

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

22.4

847

6176

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.4

22.3

155

663

L14

ICPC

Leg/thigh symptom/complaint

2.1

22.2

222

1105

R39.1

ICD-10 Finland

Other difficulties with micturition

3.0

22.1

100

344

NHQ40

NOMESCO Finland

Amputation of toe

4.0

22.1

161

G04BD08

ATC

solifenacin; oral

2.2

22.1

189

885

C08CA01

ATC

amlodipine; oral

1.5

22.0

1005

7618

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.0

22.0

239

1226

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

22.0

189

886

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

22.0

1170

9155

N06AB10

ATC

escitalopram; oral

1.7

21.9

476

3033

OAB50, ,

SPAT

2.3

21.9

166

738

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

5.1

21.9

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

21.8

354

2075

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

21.8

715

5041

M54.8

ICD-10 Finland

Other dorsalgia

2.6

21.8

124

482

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.8

21.7

113

420

C07AB07

ATC

bisoprolol; oral

1.5

21.5

1265

10080

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.2

21.5

275

G82.1

ICD-10 Finland

Spastic paraplegia

43.7

21.4

S06.0

ICD-10 Finland

Concussion

1.9

21.4

269

1453

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

4.7

21.3

106

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

9.0

21.2

R51

ICD-10 Finland

Headache

2.5

21.2

135

555

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.6

21.2

120

466

ABB10

NOMESCO Finland

Resection of lesion of spinal canal

50.4

21.1

TKC22

NOMESCO Finland

Catheterisation instruction

3.2

21.1

268

WX882

NOMESCO Finland

High dependency care

3.2

21.0

279

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.9

21.0

100

354

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.9

20.9

102

366

G992M, ,

ICD-10 Finland

+∞

20.9

G56.4

ICD-10 Finland

Causalgia

7.7

20.8

Z01.2

ICD-10 Finland

Dental examination

1.5

20.8

1099

8555

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

3.7

20.6

183

H02AB04

ATC

methylprednisolone; systemic

1.8

20.6

374

2264

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.5

20.6

207

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

2.1

20.6

214

1080

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.1

20.6

204

1012

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

20.6

416

2597

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

20.5

718

5125

R15

ICD-10 Finland

Faecal incontinence

3.0

20.5

315

M02AA07

ATC

piroxicam; topical

1.5

20.5

927

6990

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

5.3

20.3

P01AB01

ATC

metronidazole; oral, rectal

1.5

20.3

984

7522

R5140

NOMESCO Finland

Monitoring the use of the aid

1.8

20.2

315

1822

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

20.2

949

7203

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

6.2

20.2

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.9

20.2

293

1659

SPAT1310

SPAT

Counselling related to known health issue

1.5

20.2

781

5697

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

20.1

171

798

P03

ICPC

Feeling depressed

2.1

20.1

207

1041

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

8.0

20.0

M53.2

ICD-10 Finland

Spinal instabilities

5.3

19.9

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.1

19.9

206

1039

G992, M501,

ICD-10 Finland

+∞

19.8

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.9

19.8

275

1535

R55

ICD-10 Finland

Syncope and collapse

1.9

19.7

273

1521

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.1

19.6

197

982

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

19.4

626

4381

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.6

19.4

115

457

SPAT1312

SPAT

General health counselling

1.5

19.2

746

5434

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.4

19.2

132

562

N99

ICPC

Neurological disease other

4.5

19.2

107

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.4

19.2

138

600

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

3.7

19.1

169

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

4.3

19.0

116

N03AF02

ATC

oxcarbazepine; oral

2.8

18.9

347

A10BA02

ATC

metformin; oral

1.5

18.8

739

5391

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

3.3

18.8

225

ZZH31

NOMESCO Finland

Bone allograft, small pieces

4.9

18.7

C01DA14

ATC

isosorbide mononitrate; oral

1.7

18.7

372

2308

A04

ICPC

Weakness/tiredness general

1.7

18.6

338

2043

D17

ICPC

Incontinence of bowel

5.1

18.6

J01CA08

ATC

pivmecillinam; oral

1.5

18.5

862

6505

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

18.5

679

4879

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

18.5

223

1186

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.3

18.5

222

205

Kela drug reimbursment

Chronic hypertension

1.5

18.4

673

4832

NBG10

NOMESCO Finland

Acromioplastia

2.8

18.3

325

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.3

18.2

219

WX213

NOMESCO Finland

Lower leg blockade

5.2

18.2

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.9

18.1

288

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

5.4

18.1

WX290

NOMESCO Finland

Other blockage of nerve

1.4

18.1

1097

8700

R50.9

ICD-10 Finland

Fever, unspecified

1.7

18.0

370

2314

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

18.0

1601

13609

TNX92

NOMESCO Finland

Supporting bandage or orthosis of lower limb

3.4

17.9

196

SPAT1260

SPAT

Consultation of another employee

1.6

17.9

431

2809

J01CA04

ATC

amoxicillin; systemic

1.5

17.9

2044

18217

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.6

17.8

432

2819

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.1

17.8

186

940

NA1CG, ,

SPAT

7.3

17.8

E66.00

ICD-10 Finland

Metabolic syndrome

2.1

17.8

163

784

NG2AA

NOMESCO Finland

Patella X-ray examination

2.8

17.8

330

S29

ICPC

Skin symptom/complaint other

1.6

17.7

478

3201

D32.1

ICD-10 Finland

Benign neoplasm: Spinal meninges

22.9

17.7

J45.9

ICD-10 Finland

Asthma, unspecified

1.6

17.7

464

3087

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

17.6

126

546

R60.9

ICD-10 Finland

Oedema, unspecified

2.2

17.6

147

681

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

17.6

326

Z43.5

ICD-10 Finland

Attention to cystostomy

6.4

17.6

ZXA00

NOMESCO Finland

Right side

1.5

17.5

667

4822

N30.1

ICD-10 Finland

Interstitial cystitis (chronic)

4.5

17.5

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

3.0

17.4

251

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

3.9

17.4

133

M48

ICD-10 Finland

Other spondylopathies

7.8

17.4

E0000UV, ,

ATC

1.4

17.4

984

7689

WX892

NOMESCO Finland

Monitored bed care

2.0

17.3

201

1055

L84

ICPC

Back syndrome without radiat pain

2.3

17.3

133

595

R07.3

ICD-10 Finland

Other chest pain

1.8

17.3

260

1486

K59.0

ICD-10 Finland

Constipation

2.2

17.2

141

649

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.2

17.2

156

748

N05CD07

ATC

temazepam; oral

1.8

17.1

300

1794

M86.6

ICD-10 Finland

Other chronic osteomyelitis

12.6

17.1

PA7BD

NOMESCO Finland

CT angiography of neck and brain

4.4

17.1

100

S12.2

ICD-10 Finland

Fracture of other specified cervical vertebra

4.8

17.1

R03AC02

ATC

salbutamol; inhalant

1.4

17.0

1332

11017

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

6.9

17.0

G04CA02

ATC

tamsulosin; oral

1.5

17.0

621

4450

7240B

ICD-9 Finland

Other and unspecified disorders of back, Spinal stenosis, other than cervical[STENOSIS CANALIS SPINALIS LUMBOSACRALIS]

7.2

17.0

N06

ICPC

Sensation disturbance other

5.0

16.9

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

3.2

16.9

214

M41.5

ICD-10 Finland

Other secondary scoliosis

19.4

16.9

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

16.9

161

787

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

16.9

133

602

NA1BM

NOMESCO Finland

Cervical spine MRI examination with 3 Tesla magnet

22.0

16.8

SPAT1172

SPAT

Guidance concerning hydration

3.3

16.8

194

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

16.8

110

458

R02

ICPC

Shortness of breath/dyspnoea

1.7

16.8

326

2005

H02AB07

ATC

prednisone; oral

1.7

16.8

351

2203

M47.0

ICD-10 Finland

Anterior spinal and vertebral artery compression syndromes

63.7

16.7

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

2.1

16.7

166

823

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.5

16.6

101

406

J01CF05

ATC

flucloxacillin; systemic

2.1

16.6

166

825

H25.8

ICD-10 Finland

Other senile cataract

1.8

16.6

276

1625

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.5

16.6

535

3728

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

16.5

139

646

Z3231

NOMESCO Finland

Registered nurse

1.5

16.5

667

4875

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.2

16.4

139

648

N06AX26

ATC

vortioxetine; oral

2.1

16.4

161

796

WW502

NOMESCO Finland

Autotransfusion

5.7

16.3

C10AA05

ATC

atorvastatin; oral

1.4

16.3

1060

8463

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

16.3

552

3885

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

3.2

16.3

203

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.4

16.3

1364

11378

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.9

16.3

217

1194

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

16.2

165

826

WX320

NOMESCO Finland

Spinalanesthesy

1.5

16.2

615

4435

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

3.6

16.2

145

FN1AD

NOMESCO Finland

CT of coronary arteries

3.4

16.2

174

N30.9

ICD-10 Finland

Cystitis, unspecified

2.2

16.1

143

680

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

3.0

16.0

242

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.5

16.0

390

Z2446

NOMESCO Finland

Social worker

2.1

16.0

162

810

SPAT1255

SPAT

Intravenous administration of medicine

2.0

15.9

185

971

L15

ICPC

Knee symptom/complaint

1.5

15.9

586

4197

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

15.9

195

1043

A02BA02

ATC

ranitidine; systemic

1.6

15.8

477

3272

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

15.8

169

862

XA402

NOMESCO Finland

ENMG

2.9

15.7

256

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

15.6

670

4947

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

15.6

151

742

N07BA03

ATC

varenicline; oral

2.2

15.5

128

590

N32.83

ICD-10 Finland

Nozzle synergy in the bladder neck

11.8

15.5

ABD40

NOMESCO Finland

Implantation of spinal injection device

160.9

15.5

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

160.9

15.5

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.4

15.5

164

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

3.6

15.4

145

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.7

15.4

288

1753

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.8

15.4

222

1252

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

15.4

229

1304

G82.4

ICD-10 Finland

Spastic tetraplegia

38.3

15.4

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.7

15.4

304

1879

NH1AD

NOMESCO Finland

Ankle and foot CT

2.9

15.3

243

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

4.0

15.3

109

ZXA10

NOMESCO Finland

Bilateral

1.6

15.3

446

3034

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.8

15.2

254

1496

A01AB09

ATC

miconazole; local oral

1.9

15.2

211

1175

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

15.2

176

923

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

15.1

881

6877

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.7

15.1

312

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.2

15.1

192

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.7

15.1

320

2014

PD4BC

NOMESCO Finland

Extensive arterigography of lower extremity with X-ray

3.7

15.1

133

PF1BT

NOMESCO Finland

Extensive PTA of arteries of knee, lower leg and ankle

5.6

15.1

Z01.9

ICD-10 Finland

Special examination, unspecified

2.0

15.1

158

800

S14.1

ICD-10 Finland

Other and unspecified injuries of cervical spinal cord

45.3

15.1

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

4.0

15.0

106

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

15.0

1754

15384

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.6

15.0

325

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.7

14.9

J01FA09

ATC

clarithromycin; systemic

1.4

14.9

743

5637

R27.0

ICD-10 Finland

Ataxia, unspecified

6.8

14.9

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.3

14.8

113

505

R06AE07

ATC

cetirizine; oral

1.4

14.7

1010

8101

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

14.7

451

3101

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.1

14.6

206

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.7

14.6

254

1513

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.0

14.6

166

865

R06.4

ICD-10 Finland

Hyperventilation

3.7

14.6

122

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

14.6

736

5591

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.8

14.6

235

1370

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

14.6

165

859

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.8

14.5

248

1471

UDC00

NOMESCO Finland

Ear microscopy

1.9

14.5

190

1039

R03BA05

ATC

fluticasone; inhalant

1.6

14.5

424

2884

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

150.8

14.5

E10

ICD-10 Finland

Type 1 diabetes mellitus

3.2

14.4

172

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

14.3

1029

8305

E66.8

ICD-10 Finland

Other obesity

2.1

14.3

138

677

D12

ICPC

Constipation

2.4

14.3

405

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

14.2

643

4781

N02AJ13

ATC

tramadol and paracetamol; systemic

2.8

14.2

259

C10AC01

ATC

colestyramine; oral

2.7

14.2

282

D64.9

ICD-10 Finland

Anaemia, unspecified

1.7

14.2

262

1589

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

2.9

14.2

221

G04BD11

ATC

fesoterodine; oral

2.6

14.1

306

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

14.1

597

4385

D07AC01

ATC

betamethasone; topical

1.4

14.0

877

6909

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.9

14.0

186

1021

R5599

NOMESCO Finland

Other rehabilitation service

2.6

14.0

307

R32

ICD-10 Finland

Unspecified urinary incontinence

2.7

14.0

267

M01AH03

ATC

valdecoxib; oral

2.0

13.9

158

823

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

3.0

13.9

207

U07

ICPC

Urine symptom/complaint other

1.9

13.9

185

1017

C10AA01

ATC

simvastatin; oral

1.4

13.8

1036

8407

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

6.3

13.7

ZXF05

NOMESCO Finland

Interruption of procedure for other patient related reason

5.3

13.7

A10AE06

ATC

insulin degludec; parenteral

2.4

13.7

407

A10BJ02

ATC

liraglutide; parenteral

2.5

13.7

334

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

2.5

13.7

334

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.9

13.6

171

922

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.6

13.6

343

2253

9201

FHL

Anterior decompression surgery (also includes dees)

12.1

13.6

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

13.6

164

873

ABC13

NOMESCO Finland

Microsurgical excision of thoracic intervertebral disc displacement

+∞

13.5

G992, D321,

ICD-10 Finland

+∞

13.5

G91.0

ICD-10 Finland

Communicating hydrocephalus

+∞

13.5

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.5

13.5

366

NH2AA

NOMESCO Finland

Heel X-ray examination

5.5

13.5

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

2.1

13.5

128

624

318

Kela drug reimbursment

Teriparatide

5.9

13.5

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

13.5

267

1648

A10BH01

ATC

sitagliptin; oral

1.7

13.5

251

1525

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.9

13.5

211

ABC04

NOMESCO Finland

Percutaneous endoscopic discectomy for thoracic intervertebral disc displacement

140.7

13.5

M46.4

ICD-10 Finland

Discitis, unspecified

6.1

13.4

ABD99

NOMESCO Finland

Other operation on spinal cord or nerve for pain or impaired function

12.9

13.4

D43.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Spinal cord

25.9

13.4

H02AB09

ATC

hydrocortisone; systemic

2.8

13.3

234

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.6

13.3

302

1931

R52.0

ICD-10 Finland

Acute pain

2.5

13.3

345

C08CA02

ATC

felodipine; oral

1.7

13.2

233

1393

M01AX05

ATC

glucosamine; oral

1.5

13.2

480

3414

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

13.2

433

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.8

13.2

230

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

13.2

135

678

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.8

13.2

194

1101

SPAT1240

SPAT

Therapeutic discussion

1.8

13.1

215

1259

J01FA10

ATC

azithromycin; systemic

1.4

13.1

1340

11384

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

13.1

310

2005

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.2

13.1

116

552

SPAT1097

SPAT

Recording of ECG

1.6

13.0

355

2372

M02AA10

ATC

ketoprofen; topical

1.5

13.0

388

2646

ZXE00

NOMESCO Finland

One hour or less

1.4

13.0

911

7295

G63.2

ICD-10 Finland

Diabetic polyneuropathy

6.2

12.9

G62.8

ICD-10 Finland

Other specified polyneuropathies

4.0

12.9

NAW00

NOMESCO Finland

Repair of wound dehiscence in surgery of spine or neck

22.6

12.9

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

12.9

257

1591

M01AX01

ATC

nabumetone; oral

2.2

12.8

112

529

N05CF02

ATC

zolpidem; oral

1.5

12.8

416

2889

TQW11

NOMESCO Finland

Vacuum treatment of wound

2.7

12.8

251

J01AA02

ATC

doxycycline; systemic

1.4

12.7

1977

17889

TNX50

NOMESCO Finland

Removal of cutom molded cast and internal stretch

2.1

12.7

128

639

N06AX12

ATC

bupropion; oral

2.0

12.7

142

736

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

12.7

574

4257

K02.1

ICD-10 Finland

Caries of dentine

1.3

12.7

1387

11879

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

12.6

335

SPAT1104

SPAT

Monitoring of emergency patient

1.9

12.6

166

909

L09

ICPC

Arm symptom/complaint

2.1

12.5

115

554

J37.0

ICD-10 Finland

Chronic laryngitis

2.3

12.5

411

N18.8

ICD-10 Finland

Other chronic renal failure

2.6

12.5

271

G992, C795,

ICD-10 Finland

+∞

12.5

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

3.0

12.5

177

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

24.4

12.5

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.9

12.4

150

798

G90.2

ICD-10 Finland

Horner syndrome

130.6

12.4

E87.6

ICD-10 Finland

Hypokalaemia

2.3

12.4

406

J01MA01

ATC

ofloxacin; systemic

1.8

12.4

210

1241

SPAT1151

SPAT

Treatment of major wounds

3.5

12.4

117

H3601, E103,

ICD-10 Finland

4.9

12.4

U13

ICPC

Bladder symptom/complaint other

2.5

12.3

315

M04AA01

ATC

allopurinol; systemic

1.6

12.3

324

2149

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.5

12.2

316

A02BB01

ATC

misoprostol; oral

5.1

12.2

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

12.2

891

7164

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

12.2

177

1000

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.3

12.2

416

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

12.2

212

EBA00

NOMESCO Finland

Extraction of tooth

1.4

12.2

824

6545

SFA10

NOMESCO Finland

One-surface restoration

1.3

12.2

1298

11050

SFA20

NOMESCO Finland

Two-surface restoration

1.3

12.1

1397

12027

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

12.0

418

2942

M40.1

ICD-10 Finland

Other secondary kyphosis

18.1

12.0

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.3

12.0

M75.8

ICD-10 Finland

Other shoulder lesions

2.2

12.0

445

F34.1

ICD-10 Finland

Dysthymia

2.3

12.0

394

M51

ICD-10 Finland

Other intervertebral disc disorders

5.0

11.9

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

11.9

237

PA6AD

NOMESCO Finland

CT of neck arteries

2.7

11.9

243

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.8

11.9

170

956

R01AD09

ATC

mometasone; nasal

1.3

11.9

1045

8637

A07AA02

ATC

nystatin; oral

1.9

11.8

140

741

A09AA02

ATC

multienzymes (lipase, protease etc.); oral

2.6

11.7

251

A03FA02

ATC

cisapride; oral, rectal

1.8

11.7

176

1006

A02BC04

ATC

rabeprazole; oral

1.7

11.7

214

1294

H05AA02

ATC

teriparatide; parenteral

5.5

11.6

PD5AD

NOMESCO Finland

CT of aorta

2.7

11.6

235

J01FA06

ATC

roxithromycin; oral

1.3

11.6

949

7752

NC1AA

NOMESCO Finland

Elbow X-ray examination without contrast

2.3

11.6

368

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

11.6

123

627

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

11.5

217

1321

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

5.3

11.5

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.4

11.5

118

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

11.5

306

2032

XQ800

NOMESCO Finland

Prick test

1.8

11.5

166

937

C07AB02

ATC

metoprolol; systemic

1.5

11.5

462

3347

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.4

11.4

345

J01MA14

ATC

moxifloxacin; systemic

1.7

11.4

222

1364

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

11.4

415

TK800

NOMESCO Finland

Hemodialysis

2.7

11.4

237

N06AB06

ATC

sertraline; oral

1.7

11.4

237

1483

M01AC01

ATC

piroxicam; systemic, rectal

1.5

11.3

326

2204

F45.8

ICD-10 Finland

Other somatoform disorders

1.9

11.3

138

738

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.2

11.3

404

XG410

NOMESCO Finland

Flow-volume spirometry

2.1

11.2

105

510

M01AE01

ATC

ibuprofen; systemic, rectal

1.5

11.2

2293

21441

Z2445

NOMESCO Finland

Psychologist

2.3

11.2

354

L16

ICPC

Ankle symptom/complaint

1.6

11.2

264

1703

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.7

11.2

228

WX722

NOMESCO Finland

PEEP

2.0

11.2

124

642

G04CA01

ATC

alfuzosin; oral

1.5

11.1

322

2178

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.1

11.1

105

512

A06AC51

ATC

ispaghula, combinations; oral

2.0

11.1

116

587

7211A

ICD-9 Finland

Spondylosis and allied disorders, Cervical spondylosis with myelopathy

25.1

11.1

G82.0

ICD-10 Finland

Flaccid paraplegia

25.1

11.1

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

2.8

11.1

189

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

11.1

233

1460

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

11.1

362

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.9

11.1

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

11.1

280

1836

JN4AD

NOMESCO Finland

Body CT examination

1.6

11.1

254

1627

J04AB02

ATC

rifampicin; systemic

3.3

11.1

121

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.3

11.1

126

ZXA05

NOMESCO Finland

Left side

1.4

11.1

589

4484

A10BH05

ATC

linagliptin; oral

2.0

11.1

123

637

SPAT1325

SPAT

Vaccination

1.4

11.0

761

6044

R03BB04

ATC

tiotropium bromide; inhalant

1.6

11.0

254

1629

XA800

NOMESCO Finland

Neuropsychological investigation

2.1

11.0

461

SPAT1050

SPAT

Extensive neurological examination

2.8

11.0

185

R26.2

ICD-10 Finland

Difficulty in walking, not elsewhere classified

3.2

11.0

132

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

2.6

11.0

242

A02BA04

ATC

nizatidine; systemic

1.8

10.9

180

1056

J45.8

ICD-10 Finland

Mixed asthma

2.4

10.9

327

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.4

10.9

517

3856

N06AB03

ATC

fluoxetine; oral

1.6

10.9

280

1843

AB3CB

NOMESCO Finland

Lumbar myelography

43.5

10.9

A10BB01

ATC

glibenclamide; oral

2.2

10.9

397

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

2.8

10.9

186

N05BA12

ATC

alprazolam; oral

1.6

10.8

238

1509

M77.1

ICD-10 Finland

Lateral epicondylitis

1.8

10.8

178

1044

L04AA01

ATC

[U] ciclosporin

3.3

10.8

123

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

3.7

10.8

J01DA09

ATC

[U] cefadroxil

1.4

10.8

600

4602

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.1

10.7

452

ZSN00

NOMESCO Finland

Procedure related to previous procedure classified in chapter N

4.9

10.7

JF1AD

NOMESCO Finland

Small bowel CT

4.6

10.7

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

10.7

193

1162

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

10.6

139

760

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.0

10.6

122

639

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

60.2

10.6

C08CA13

ATC

lercanidipine; oral

1.5

10.6

342

2368

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

10.6

155

879

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

3.9

10.6

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

10.5

119

621

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

10.5

119

621

U28

ICPC

Limited function/disability (U)

3.6

10.5

NE1AD

NOMESCO Finland

Pelvis and hip bones CT examination

2.5

10.4

254

A11

ICPC

Chest pain NOS

1.7

10.4

197

1201

ABC33

NOMESCO Finland

Decompression of thoracic nerve roots

110.4

10.4

R31

ICD-10 Finland

Unspecified haematuria

1.6

10.4

242

1556

A10BJ06

ATC

semaglutide; parenteral

1.9

10.4

130

701

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

10.4

396

2836

WX872

NOMESCO Finland

Intensive care

1.9

10.4

130

702

NAW10

NOMESCO Finland

Reoperation for superficial infection in in surgery of spine or neck

16.1

10.3

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

10.3

174

1028

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

10.3

511

3838

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.7

10.3

203

Z71.8

ICD-10 Finland

Other specified counselling

1.4

10.2

667

5241

L99

ICPC

Musculoskeletal disease other

2.7

10.2

198

ZZA00

NOMESCO Finland

Split skin graft

2.3

10.2

318

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.1

10.2

482

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

10.2

508

3820

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.1

10.2

422

N31.0

ICD-10 Finland

Uninhibited neuropathic bladder, not elsewhere classified

7.5

10.2

N06AX17

ATC

milnacipran; oral

3.5

10.2

Z46.9

ICD-10 Finland

Fitting and adjustment of unspecified device

3.4

10.1

108

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

3.3

10.1

118

R25.2

ICD-10 Finland

Cramp and spasm

2.5

10.1

258

U02

ICPC

Urinary frequency/urgency

1.5

10.1

302

2057

N01

ICPC

Headache

1.7

10.1

204

1267

ND1AA

NOMESCO Finland

Wrist X-ray examination

1.8

10.1

154

885

L04AA13

ATC

[U] leflunomide

2.4

10.0

271

D07AD01

ATC

clobetasol; topical

1.5

10.0

384

2750

A11CC03

ATC

alfacalcidol; systemic

2.4

10.0

265

K07.61

ICD-10 Finland

Cracking jaw joint

2.9

10.0

161

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

1.7

10.0

167

984

AA1AA

NOMESCO Finland

Head X-ray examination

4.8

10.0

7227A

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[KAULANIKAMAN VÄLILEVYTYRÄ JUURIOIREINEEN]

10.1

10.0

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.7

10.0

189

R01AD08

ATC

fluticasone; nasal

1.4

10.0

642

5031

A07AA09

ATC

vancomycin; oral

3.0

10.0

140

U05

ICPC

Urination problems other

1.9

10.0

123

661

M01AB01

ATC

indometacin; systemic, rectal

1.7

9.9

190

1162

Z04.9

ICD-10 Finland

Examination and observation for unspecified reason

2.0

9.9

101

507

M65.3

ICD-10 Finland

Trigger finger

1.9

9.9

121

647

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.2

9.9

380

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

2.6

9.9

219

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.4

9.9

267

T91.8

ICD-10 Finland

Sequelae of other specified injuries of neck and trunk

16.8

9.9

SPAT1284

SPAT

Extensive health certificate

2.5

9.9

249

J01XX08

ATC

linezolid; systemic

4.3

9.8

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.4

9.8

280

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.2

9.8

369

NAG99

NOMESCO Finland

Other excision, reconstruction or fusion of joints of spine, unspecified

20.1

9.8

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.3

9.8

331

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

9.8

576

4451

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

3.2

9.7

121

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

9.7

1610

14371

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

9.7

124

674

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

4.1

9.7

KED33

NOMESCO Finland

Transurethral incision of prostate

3.0

9.7

137

S76

ICPC

Skin infection other

1.9

9.7

127

696

D11

ICPC

Diarrhoea

1.6

9.7

238

1551

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

9.7

443

3280

N06AX03

ATC

mianserin; oral

1.9

9.6

116

619

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.7

9.6

187

1150

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

9.6

660

5223

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.3

9.6

107

R03DC03

ATC

montelukast; oral

1.5

9.6

359

2560

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

9.6

545

4186

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

9.6

160

944

NGQ20

NOMESCO Finland

Amputation of lower leg

4.6

9.5

I79.2*E11.5

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy

9.1

9.5

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

2.9

9.5

155

ZA1.0

ICD-10 Finland

Shoulder region

2.4

9.5

260

A07EC01

ATC

sulfasalazine; oral, rectal

1.7

9.5

187

1154

I65.2

ICD-10 Finland

Occlusion and stenosis of carotid artery

2.9

9.4

150

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

9.4

528

4044

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

9.4

121

659

H03AA01

ATC

levothyroxine sodium; systemic

1.4

9.4

510

3884

NA1BD

NOMESCO Finland

Extensive cervical spine CT examination

30.1

9.4

XF402

NOMESCO Finland

ECG with work load test

1.6

9.4

255

1700

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.8

9.4

147

851

G95.1

ICD-10 Finland

Vascular myelopathies

+∞

9.4

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

+∞

9.4

A29

ICPC

General symptom/complaint other

1.5

9.4

283

1931

J01MA06

ATC

norfloxacin; oral

1.5

9.4

285

1948

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

9.3

286

1958

R20.0

ICD-10 Finland

Anaesthesia of skin

4.5

9.3

25002

ICD-8 Finland

Diabetes mellitus, Retinopathia diabetica

10.7

9.3

R41.0

ICD-10 Finland

Disorientation, unspecified

2.3

9.3

294

NA2DG

NOMESCO Finland

Thoracal spine very extensive MRI examination with high intensity magnet

9.5

9.3

R26.0

ICD-10 Finland

Ataxic gait

9.5

9.3

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.1

9.3

418

WX720

NOMESCO Finland

Own respiration

1.9

9.2

113

606

H02.4

ICD-10 Finland

Ptosis of eyelid

2.2

9.2

346

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.4

9.2

276

G35

ICD-10 Finland

Multiple sclerosis

3.2

9.2

115

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

9.2

354

2537

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.7

9.2

175

C03DA01

ATC

spironolactone; oral

1.5

9.2

270

1833

C01CA24

ATC

epinephrine; parenteral

1.8

9.1

130

731

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

9.1

127

709

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

9.1

187

1165

JG1JB

NOMESCO Finland

Defekography with X-ray

3.9

9.1

M03BB53

ATC

chlorzoxazone, combinations excl. psycholeptics; oral

3.1

9.1

121

M96.0

ICD-10 Finland

Pseudarthrosis after fusion or arthrodesis

4.4

9.1

EBA10

NOMESCO Finland

Operative extraction of tooth

1.6

9.1

237

1566

T91.1

ICD-10 Finland

Sequelae of fracture of spine

11.5

9.1

K08.80

ICD-10 Finland

Toothache NOS

1.7

9.1

185

1152

KCV04

NOMESCO Finland

Distension of bladder with fluid

3.8

9.1

M89.0

ICD-10 Finland

Algoneurodystrophy

4.0

9.0

C09AA05

ATC

ramipril; oral

1.4

9.0

584

4571

D07AB08

ATC

desonide; topical

1.6

9.0

234

1544

D33.4

ICD-10 Finland

Benign neoplasm: Spinal cord

36.8

9.0

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.5

9.0

259

1749

A99

ICPC

Disease/condition unspecnature/site

1.6

9.0

208

1336

A10BJ05

ATC

dulaglutide; parenteral

2.5

9.0

230

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

9.0

107

569

XG466

NOMESCO Finland

Sleep oxymetry

2.1

8.9

390

C09AA02

ATC

enalapril; systemic

1.4

8.9

444

3330

TAD08

NOMESCO Finland

Sympathetic block on sacral Level

18.7

8.9

J01DC02

ATC

cefuroxime; systemic

1.8

8.9

124

693

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.6

8.9

231

1524

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

2.8

8.9

161

R03BA08

ATC

ciclesonide; inhalant

1.6

8.9

195

1237

NB1AT

NOMESCO Finland

Puncture of shoulder with ultrasound guidance

3.9

8.9

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.3

8.9

E000001, ,

ATC

1.4

8.8

422

3143

SPAT1234

SPAT

Support of social functional capacity

1.9

8.8

109

586

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

8.8

428

3196

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.5

8.8

R4120, ,

SPAT

3.6

8.8

H81.3

ICD-10 Finland

Other peripheral vertigo

2.3

8.8

275

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

2.7

8.8

173

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

8.8

382

2798

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

8.8

155

929

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

8.7

394

M01AB08

ATC

etodolac; oral

1.6

8.7

180

1125

K90

ICPC

Stroke/cerebrovascular accident

2.3

8.7

277

S70.0

ICD-10 Finland

Contusion of hip

2.0

8.7

456

Y84

ICD-10 Finland

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

8.7

S01.0

ICD-10 Finland

Open wound of scalp

1.6

8.7

179

1118

SFA30

NOMESCO Finland

Three-surface restoration

1.3

8.7

1011

8582

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.5

8.6

210

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

3.3

8.6

S94

ICPC

Ingrowing nail

2.7

8.6

158

QXB99, ,

SPAT

2.4

8.6

247

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.7

8.6

147

873

N32.0

ICD-10 Finland

Bladder-neck obstruction

4.0

8.6

R20.1

ICD-10 Finland

Hypoaesthesia of skin

4.8

8.6

K08.3

ICD-10 Finland

Retained dental root

1.6

8.6

179

1121

SPAT1304

SPAT

Counselling and guidance related to ageing

1.7

8.6

152

912

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.2

8.6

337

A08AB01

ATC

orlistat; oral

3.6

8.6

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

8.5

488

SPAT1266

SPAT

Separate instruction to prepare for procedure

2.2

8.5

306

J20

ICD-10 Finland

Acute bronchitis

1.6

8.4

223

1478

L18

ICPC

Muscle pain

2.0

8.4

461

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.5

8.4

246

1668

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.7

8.4

139

819

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

2.0

8.4

414

M05BA07

ATC

risedronic acid; oral

2.2

8.4

301

A12AA04

ATC

calcium carbonate; oral

2.7

8.4

155

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

8.4

367

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

8.3

526

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

2.4

8.3

232

G93.0

ICD-10 Finland

Cerebral cysts

+∞

8.3

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

+∞

8.3

G992, M513,

ICD-10 Finland

+∞

8.3

NB1AD

NOMESCO Finland

Shoulder CT examination

2.6

8.3

184

PA6AE

NOMESCO Finland

Ulrasound examination of neck vasculature

4.0

8.3

M75

ICD-10 Finland

Shoulder lesions

1.9

8.3

102

548

WX702

NOMESCO Finland

Supraglottic ventilation device

1.7

8.3

134

783

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.1

8.3

388

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

3.1

8.3

112

K30

ICD-10 Finland

Functional dyspepsia

1.5

8.2

242

1641

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.3

8.2

265

G04BD09

ATC

trospium; oral

2.4

8.2

240

P76

ICPC

Depressive disorder

1.8

8.2

123

704

L89

ICPC

Osteoarthrosis of hip

2.0

8.2

466

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.5

8.2

301

2138

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

8.2

113

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

2.1

8.1

391

ZY010

NOMESCO Finland

Hospital outpatient

1.9

8.1

102

552

B01AB10

ATC

tinzaparin; parenteral

1.5

8.1

231

1556

G50.0

ICD-10 Finland

Trigeminal neuralgia

2.6

8.1

169

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

2.6

8.1

169

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.7

8.1

152

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

8.1

SPAT1279

SPAT

Preparation of immediate hospitalisation

3.4

8.1

G06.1

ICD-10 Finland

Intraspinal abscess and granuloma

17.2

8.1

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.9

8.1

130

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.9

8.1

130

A10BK03

ATC

empagliflozin; oral

1.5

8.1

238

1616

C03AA03

ATC

hydrochlorothiazide; oral

1.6

8.1

207

1363

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.0

8.0

434

TQW40, ,

SPAT

1.6

8.0

175

1108

NA7AD

NOMESCO Finland

Spine CT

10.0

8.0

TQW40

NOMESCO Finland

Remowal of suture of skin

1.6

8.0

165

1030

2402

FHL

External neurolysis of the nerve and possible alteration of the pathway (nerve pressure)

2.6

8.0

170

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.0

8.0

414

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.8

8.0

115

650

R00.2

ICD-10 Finland

Palpitations

1.6

8.0

165

1032

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.2

8.0

301

U01

ICPC

Dysuria/painful urination

1.7

8.0

152

931

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

3.2

8.0

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.6

7.9

165

SFA00

NOMESCO Finland

Small restoration

1.4

7.9

307

2200

NHQ30

NOMESCO Finland

Amputation of foot, transmetatarsal

4.3

7.9

L70.0

ICD-10 Finland

Acne vulgaris

3.3

7.9

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

7.9

156

963

RS221, ,

NOMESCO Finland

2.8

7.9

137

SPAT1360

SPAT

Extensive global examination

1.7

7.9

147

894

3540A

ICD-9 Finland

Mononeuritis of upper limb and mononeuritis multiplex, Carpal tunnel syndrome

3.0

7.9

110

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

7.9

685

5582

N17

ICPC

Vertigo/dizziness

1.5

7.9

255

1765

K05.31

ICD-10 Finland

Periodontitis pronounced

1.5

7.9

267

1866

D06

ICPC

Abdominal pain localized other

1.6

7.8

172

1091

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.3

7.8

555

4394

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.4

7.8

214

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.6

7.8

178

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

7.8

133

790

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

7.8

387

2899

SPAT1058

SPAT

PEF monitoring instruction

1.6

7.8

180

1157

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.9

7.8

525

S21

ICPC

Skin texture symptom/complaint

1.4

7.7

308

2219

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

7.7

162

1016

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

7.7

276

1948

Z71.9

ICD-10 Finland

Counselling, unspecified

1.7

7.7

149

915

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.5

7.7

216

1450

D33.43

ICD-10 Finland

Spinal cord

45.1

7.7

G59.0*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic mononeuropathy

45.1

7.7

XX1VW

NOMESCO Finland

Written report from radiologist

3.5

7.7

G04BD07

ATC

tolterodine; oral

1.8

7.7

107

599

P20

ICPC

Memory disturbance

1.5

7.7

282

2001

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.7

7.7

145

F32.1

ICD-10 Finland

Moderate depressive episode

1.8

7.7

111

629

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

3.4

7.7

E870A

ICD-9 Finland

Accidental cut, puncture, perforation or haemorrhage during medical care

3.3

7.7

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

7.6

179

1154

E000006, ,

ATC

1.7

7.6

138

833

B01AB04

ATC

dalteparin; parenteral

1.8

7.6

116

667

WX120

NOMESCO Finland

Intravenous local anesthesy of arm

2.6

7.6

157

L11

ICPC

Wrist symptom/complaint

1.6

7.6

176

1131

Q07.0

ICD-10 Finland

Arnold-Chiari syndrome

18.4

7.6

NA7FT

NOMESCO Finland

Labeling lesion in spinal area with X-ray guidance

18.4

7.6

F44.4

ICD-10 Finland

Dissociative motor disorders

18.4

7.6

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.5

7.6

208

1390

WVA20

NOMESCO Finland

Medicine administration

2.2

7.6

281

D07AC13

ATC

mometasone; topical

1.3

7.6

649

5274

M01AB16

ATC

aceclofenac; oral

2.0

7.6

395

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.0

7.6

368

N05AA02

ATC

levomepromazine; systemic

1.9

7.5

501

TNX30

NOMESCO Finland

Soft bandage, unspecified region

2.8

7.5

135

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

4.1

7.5

G24.3

ICD-10 Finland

Spasmodic torticollis

3.2

7.5

NA2BG, ,

SPAT

3.8

7.5

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

7.5

431

3304

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.0

7.5

417

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

7.5

246

1707

C08CA05

ATC

nifedipine; systemic

1.7

7.5

125

738

B01AF01

ATC

rivaroxaban; oral

1.4

7.5

301

2172

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.7

7.5

147

OAB93, ,

SPAT

1.8

7.5

103

575

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.1

7.5

309

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.9

7.5

460

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.0

7.4

370

UJD02

NOMESCO Finland

Gastroscopy

1.8

7.4

109

620

N05AB04

ATC

prochlorperazine; systemic, rectal

2.4

7.4

207

F32

ICD-10 Finland

Depressive episode

1.8

7.4

100

554

B01AC07

ATC

dipyridamole; systemic

2.1

7.4

343

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3044640) Blood type and Crossmatch panel - Blood

1282

7006

2.59

124.41

3.1

2.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1675

10397

2.63

124.14

13.0

15.0

1.18

1.28

inr

4.71

458

3013

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1196

6402

2.57

120.14

2.5

2.1

223.28

243.49

u/l

0.28

1128

5980

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1661

10384

2.57

119.36

3.4

2.6

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1900

13017

2.58

106.65

6.7

4.7

6.96

6.77

mmol/l

2.93

1837

12234

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1679

11013

2.40

101.45

8.7

6.9

1.21

mmol/l

1.01

1396

9368

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1534

10018

2.24

88.73

7.8

6.1

1.21

mmol/l

1.05

1383

9128

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

985

5391

2.31

87.57

3.0

2.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1326

8410

2.14

79.50

4.6

3.5

114.53

52.52

ng/l

0.57

1020

5870

(3026008) Bacteria identified in Urine by Culture

1061

6364

2.10

71.63

4.6

3.0

—

(3013707) Erythrocyte sedimentation rate by Westergren method

2100

16372

2.30

68.53

5.7

4.0

14.24

12.30

mm/h

5.82

1954

15111

(3023368) Bacteria identified in Blood by Culture

1017

6114

2.07

67.23

6.0

4.4

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1966

15038

2.15

65.58

6.5

4.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1351

9053

1.99

65.22

2.3

2.0

94.84

94.90

pmol/l

0.01

727

4725

(3013512) EKG study

1084

6725

2.03

65.20

5.1

3.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1110

7029

1.99

62.22

3.4

2.6

117.93

60.15

u/l

0.42

1036

6479

(3024561) Albumin [Mass/volume] in Serum or Plasma

1408

9699

1.95

61.35

5.9

4.9

34.81

35.46

g/l

3.83

1308

9031

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2161

17436

2.23

58.66

9.5

7.7

80.65

78.71

u/l

0.63

2040

16459

(3031040) Bacteria [#/volume] in Urine by Automated count

1853

14191

1.99

57.02

6.7

4.2

355.19

1905.12

e6/l

1.82

201

(3042936) Bacteria identified in Isolate by Culture

610

3208

2.17

55.73

3.0

2.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1605

11812

1.89

54.47

6.5

6.4

10.25

11.63

umol/l

2.34

1516

11237

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1019

6485

1.92

54.41

3.0

1144.07

1376.45

ng/l

1.36

860

5520

(3019309) Folate [Moles/volume] in Red Blood Cells

710

4019

2.04

53.01

2.0

1.7

1114.95

1176.89

nmol/l

0.97

539

3013

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

636

3549

2.04

48.86

2.1

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1271

8886

1.82

48.81

2.7

2.2

77.30

77.84

nmol/l

0.28

1155

7966

(3021960) Folate [Moles/volume] in Serum or Plasma

827

5069

1.91

48.27

1.7

1.5

20.17

20.71

nmol/l

0.43

686

4314

(3012095) Magnesium [Moles/volume] in Serum or Plasma

647

3650

2.02

48.12

3.6

3.4

0.82

mmol/l

0.03

597

3443

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

787

4763

1.92

47.62

2.0

1.7

1.07

1.21

mg/l

0.85

593

3677

(3003458) Phosphate [Moles/volume] in Serum or Plasma

546

2922

2.09

46.77

8.1

6.1

1.06

1.03

mmol/l

0.95

521

2721

(40760892) CBC W Ordered Manual Differential panel - Blood

1425

10393

1.79

46.73

7.9

6.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2033

16612

1.92

44.87

4.7

3.8

14.94

14.83

pmol/l

1.17

1845

15051

(3026782) Osmolality of Urine

736

4437

1.91

44.58

3.8

2.8

528.31

547.50

mosm/kgh2o

1.70

668

3784

(3019069) Monocytes/100 leukocytes in Blood

1416

10397

1.77

44.54

8.2

6.4

8.50

8.71

1.64

1334

9732

(3003396) Base excess in Arterial blood by calculation

492

2577

2.11

44.40

6.9

7.6

1.11

1.16

mmol/l

0.13

412

2052

(3002030) Lymphocytes/100 leukocytes in Blood

1443

10659

1.77

44.39

7.8

6.2

26.65

27.55

2.48

1360

10000

(3036481) Cortisol [Moles/volume] in Serum or Plasma

400

1937

2.25

43.97

2.2

2.1

341.80

373.89

nmol/l

2.92

362

1768

(3006504) Eosinophils/100 leukocytes in Blood

1407

10348

1.76

43.66

7.7

6.1

2.91

2.86

0.40

1326

9672

(3019225) pH of Specimen

451

2303

2.15

43.39

5.0

4.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

488

2579

2.09

42.88

6.9

7.6

13.40

12.18

kpa

4.24

468

2459

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

488

2579

2.09

42.88

6.9

7.6

5.23

5.12

kpa

1.71

469

2457

(3037522) Nuclear Ab [Titer] in Serum

524

2851

2.04

42.51

1.4

1.3

461.71

510.56

titre

0.25

105

610

(3007853) Bacteria identified in Skin by Aerobe culture

483

2551

2.09

42.47

2.5

1.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2492

22138

2.77

42.39

24.9

14.2

22.44

24.67

mg/l

3.00

2160

17480

(3018010) Neutrophils/100 leukocytes in Blood

1417

10498

1.74

42.34

7.4

6.0

58.08

57.40

1.39

1332

9839

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1822

14516

1.80

41.98

4.3

3.1

60.40

52.75

u/l

1.52

1692

13439

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

754

4659

1.86

41.86

1.9

1.7

20820105.69

38773813.96

pmol/l

0.51

610

3848

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

1139

7956

1.75

41.81

4.4

3.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2336

20206

2.21

41.71

5.8

4.6

1.89

2.09

mu/l

1.20

2134

18379

(3022096) Basophils/100 leukocytes in Blood

1366

10047

1.73

41.62

7.6

6.1

0.68

0.03

1282

9378

(3019198) Lymphocytes [#/volume] in Blood

1495

11292

1.73

41.22

7.2

5.9

1.90

1.92

e9/l

0.15

1371

9957

(3013115) Eosinophils [#/volume] in Blood

1507

11420

1.73

40.94

7.4

6.1

0.21

0.19

e9/l

2.09

1364

9966

(3001604) Monocytes [#/volume] in Blood

1463

11003

1.73

40.79

7.2

5.8

0.61

0.59

e9/l

2.07

1322

9482

(3006315) Basophils [#/volume] in Blood

1466

11033

1.73

40.77

7.2

5.8

0.04

e9/l

1.50

1322

9497

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

148

447

3.45

40.55

1.7

1.2

636.21

546.19

mg/l

0.62

140

416

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

845

5460

1.80

40.24

2.6

2.2

3.05

3.00

mg/l

0.20

717

4630

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1232

8864

1.72

40.16

3.7

2.8

140.32

146.91

ug/l

0.42

1119

8187

(3009343) pH of Capillary blood

312

1416

2.36

39.73

4.5

3.7

7.41

0.12

183

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

313

1436

2.34

38.85

4.5

3.7

5.27

5.15

kpa

1.76

299

1366

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

620

3678

1.89

38.67

1.3

35.56

35.63

iu/ml

0.00

186

1212

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

227

903

2.65

38.26

5.7

4.9

1.76

1.65

0.85

219

836

(3016502) Oxygen saturation in Arterial blood

437

2314

2.06

37.82

7.0

8.0

96.07

95.58

1.12

422

2225

(3022948) Iron [Moles/volume] in Serum or Plasma

584

3437

1.89

37.15

3.3

2.5

11.59

13.23

umol/l

6.65

537

3209

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

327

1566

2.24

36.57

1.9

1.6

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

446

2409

2.02

36.44

4.9

3.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

221

892

2.61

36.13

5.9

5.0

0.98

0.89

1.62

214

825

(3044290) Cell count panel - Cerebral spinal fluid

125

367

3.52

35.76

1.8

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

295

1368

2.30

35.59

4.6

3.6

1.94

1.84

mmol/l

0.16

235

1008

(3020682) Albumin/Creatinine [Ratio] in Urine

1038

7315

1.68

35.14

4.7

3.9

14.68

8.73

mg/mmol

2.39

714

4601

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

271

1229

2.34

34.40

8.6

10.6

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

301

1428

2.25

34.35

2.6

2.4

15.28

21.91

au/ml

0.59

(3033658) Prothrombin time (PT) actual/Normal

837

5625

1.71

33.48

4.8

3.9

91.48

89.62

1.34

808

5491

(3022313) Gas panel - Capillary blood

237

1031

2.42

33.00

4.9

3.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

277

1294

2.27

32.75

1.4

1.3

91.10

61.21

au/ml

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

398

2147

2.00

32.37

7.7

8.4

121.80

122.39

g/l

0.22

390

2080

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

123

382

3.33

32.23

1.9

1.3

358.10

1580.79

e6/l

0.92

103

306

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

123

382

3.33

32.23

1.7

1.2

16.49

26.00

e6/l

0.23

287

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

512

3011

1.87

32.15

3.5

2.6

20.85

23.27

3.15

427

2581

(3019550) Sodium [Moles/volume] in Serum or Plasma

2536

23197

2.71

31.92

27.6

16.3

139.51

139.72

mmol/l

4.05

2499

22601

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

127

408

3.22

31.50

1.6

1.1

3.96

3.82

mmol/l

0.50

117

385

(3004789) Transferrin [Mass/volume] in Serum or Plasma

533

3193

1.84

31.48

3.4

2.5

2.29

2.31

g/l

0.25

488

2949

(3018677) aPTT in Platelet poor plasma by Coagulation assay

529

3166

1.84

31.32

2.6

2.1

29.45

29.89

0.84

505

3065

(3000850) Epithelial cells [#/volume] in Urine

710

4636

1.72

31.16

3.3

2.5

5.35

5.28

e6/l

0.05

660

4154

(3020630) Protein [Mass/volume] in Serum or Plasma

355

1871

2.03

30.72

2.6

2.7

65.59

66.60

g/l

1.48

326

1715

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

680

4407

1.73

30.57

1.3

1.2

1.82

1.53

u/ml

0.16

156

1146

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

215

927

2.43

30.49

2.0

1.9

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2536

23267

2.65

30.41

27.8

16.4

4.00

3.98

mmol/l

3.15

2498

22641

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

488

2876

1.85

30.26

5.0

4.6

32.15

32.29

0.10

368

1914

(3047181) Lactate [Moles/volume] in Blood

176

692

2.65

30.26

6.7

5.9

1.21

1.38

mmol/l

1.41

159

596

(3012516) Albumin [Mass/volume] in Urine

974

6950

1.63

30.21

4.0

3.3

668.98

283.99

mg/l

1.28

656

4397

(3005719) IgG [Mass/volume] in Serum or Plasma

320

1633

2.09

30.20

3.0

2.8

9.74

10.74

g/l

3.47

283

1486

(3009508) Creatinine [Moles/volume] in Urine

1004

7221

1.62

30.14

3.8

3.2

7.32

7.63

mmol/l

1.49

828

6073

(3018572) Chloride [Moles/volume] in Blood

140

489

2.97

30.09

7.0

6.7

105.34

105.29

mmol/l

0.04

132

428

(3039000) Anion gap in Blood

140

489

2.97

30.09

7.0

6.7

10.35

11.36

mmol/l

2.97

132

428

(3009261) Glucose [Presence] in Urine by Test strip

1379

10713

1.59

29.87

4.8

3.5

0.00

estimate

1.08

279

1919

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

278

1349

2.18

29.87

6.3

8.0

24.96

24.92

mmol/l

0.07

273

1342

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

190

783

2.54

29.67

2.6

2.4

340.11

549.19

ug/l

0.99

174

741

(3035350) Ketones [Presence] in Urine by Test strip

1366

10600

1.59

29.64

4.7

3.5

0.00

estimate

0.22

316

2117

(3021601) Nitrite [Presence] in Urine by Test strip

1365

10591

1.59

29.63

6.4

4.8

0.00

estimate

0.50

296

1997

(3015736) pH of Urine

1139

8486

1.59

29.29

4.0

3.2

5.93

5.76

0.72

609

(3002582) Erythrocytes [#/volume] in Urine

942

6711

1.62

29.16

4.4

3.2

210.74

99.87

e6/l

0.41

810

5174

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

150

4.63

28.76

1.8

1.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1001

7266

1.60

28.52

3.4

3.2

33.36

36.69

u/l

0.76

948

6896

(3019060) Gas panel - Arterial blood

294

1485

2.10

28.44

5.2

4.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1589

12857

1.58

28.15

9.9

9.2

4.32

4.12

e9/l

2.59

1443

11223

(3026493) Urate [Moles/volume] in Serum or Plasma

866

6085

1.62

28.13

3.2

2.7

4145.22

5051.01

umol/l

0.29

756

5348

(3030467) Casts [#/volume] in Urine by Automated count

873

6147

1.62

28.12

4.3

3.1

0.31

0.45

e6/l

1.93

751

4681

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

558

3514

1.74

27.41

1.3

24.18

12.34

u/ml

0.43

186

1353

(3020779) Urea [Moles/volume] in Serum or Plasma

366

2026

1.93

27.34

10.0

7.7

10.01

10.03

mmol/l

0.02

353

1931

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

139

4.62

26.65

1.3

1.1

45.43

39.78

mg/l

0.45

114

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

139

4.62

26.65

1.6

1.2

2.20

2.21

mmol/l

0.02

131

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2328

20861

1.88

26.63

8.1

5.8

41.80

40.00

mmol/mol

12.77

2167

19247

(3004588) Protein electrophoresis panel - Serum or Plasma

297

1558

2.02

25.84

2.6

2.5

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

191

841

2.37

25.79

1.9

1.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

307

1634

1.99

25.63

5.3

4.0

95.34

91.38

ng/l

0.29

263

1424

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

197

882

2.33

25.61

5.5

3.8

25.12

24.82

mmol/l

0.71

188

821

(3008152) Bicarbonate [Moles/volume] in Arterial blood

272

1391

2.06

25.36

7.6

6.8

25.24

24.62

mmol/l

2.34

264

1314

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

137

4.53

25.26

1.3

1.0

379.65

285.92

mg/l

0.79

114

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

309

3.25

25.08

8.2

6.3

11.35

11.46

mg/l

0.10

291

(3015377) Calcium [Moles/volume] in Serum or Plasma

1008

7496

1.55

24.98

3.0

3.5

2.34

2.35

mmol/l

1.09

865

6612

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

205

946

2.26

24.81

1.9

2.0

3.87

1.85

ug/l

0.51

181

844

(3018095) Leukocytes [#/volume] in Urine

1036

7760

1.55

24.80

5.1

3.6

145.73

104.90

e6/l

0.34

848

5538

(3007164) IgA [Mass/volume] in Serum or Plasma

597

3937

1.66

24.38

1.6

1.5

2.43

2.53

g/l

0.55

358

2418

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

427

2580

1.78

23.93

3.9

4.2

243.04

247.86

u/l

0.26

399

2442

(3016018) Differential panel - Cerebral spinal fluid

189

3.83

23.50

2.0

1.2

—

(3000494) Fungus identified in Specimen by Culture

439

2690

1.76

23.40

1.8

1.4

—

(3012544) pH of Venous blood

362

2095

1.84

23.37

5.5

3.8

7.37

—

(40761511) CBC panel - Blood by Automated count

2496

23094

2.17

23.26

23.9

13.4

—

(3018418) pH of Serum or Plasma

889

6515

1.55

23.09

5.7

4.1

7.40

0.27

209

1247

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

107

4.84

22.94

2.0

1.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

132

4.31

21.84

1.2

1.0

—

(3048689) Calprotectin [Mass/mass] in Stool

397

2416

1.75

21.55

2.1

2.3

195.08

152.11

ug/g

0.90

307

1960

(40768797) Stomach Pathology biopsy report

490

3165

1.67

21.37

1.3

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

250

1326

1.98

20.96

4.3

3.1

126.61

128.84

g/l

0.72

239

1291

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

148

640

2.39

20.80

2.4

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

231

1198

2.02

20.63

7.2

10.4

24.58

24.44

mmol/l

0.29

223

1168

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

163

739

2.28

20.55

1.6

120.00

218.13

titre

—

(36304419) Bacteria [Presence] in Urine

814

5981

1.52

20.33

4.3

3.0

—

(3002032) Base excess in Venous blood by calculation

340

2025

1.78

19.79

5.6

3.8

2.08

1.99

mmol/l

0.16

300

1701

(3021447) Carbon dioxide [Partial pressure] in Venous blood

341

2035

1.77

19.71

5.6

3.8

5.86

5.85

kpa

0.06

332

1972

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

113

444

2.61

19.47

1.8

1.7

—

(3017732) Neutrophils [#/volume] in Blood

274

1538

1.87

19.34

3.2

4.57

5.04

e9/l

0.22

218

1244

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1045

8152

1.46

19.09

5.2

3.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

244

1325

1.93

19.06

1.9

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

203

1036

2.04

18.94

4.2

3.4

25.51

25.28

mmol/l

0.33

197

1004

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

389

2439

1.70

18.80

2.0

1.7

—

(3024869) Neuronal Ab [Presence] in Serum

7.71

18.69

1.1

—

(3041096) Erythrocytes [Presence] in Urine by Automated

770

5696

1.49

18.23

4.9

3.3

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2532

23826

2.12

18.18

27.0

16.7

81.22

78.54

umol/l

2.36

2532

23818

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

522

3552

1.58

18.14

3.8

2.9

1.96

2.16

e6/l

0.31

332

1933

(3027945) Reticulocytes/100 erythrocytes in Blood

399

2543

1.67

18.09

2.7

2.6

1.84

1.81

0.21

353

2267

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

386

2448

1.67

17.82

2.1

1.7

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

605

4289

1.53

17.44

4.6

3.6

279.29

664.20

ng/l

0.97

477

3423

(3000570) Elastase.pancreatic [Mass/mass] in Stool

140

640

2.25

17.32

1.7

1.4

262.73

282.15

ug/g

0.49

377

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

545

3787

1.55

17.18

3.5

2.7

1.11

1.05

e6/l

0.20

354

2163

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

177

3.44

17.14

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

317

1926

1.73

17.11

2.7

2.6

69.89

70.67

e9/l

0.15

253

1466

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

208

3.23

16.98

2.8

2.6

—

(40761536) Microorganisms panel - Urine sediment

306

1850

1.74

16.80

6.2

3.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

124

3.92

16.63

1.5

1.7

—

(36660697) Celiac disease serology panel - Serum

266

1553

1.79

16.47

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

112

478

2.40

16.24

3.7

3.1

1.60

1.54

mmol/l

0.35

107

461

(3024354) Oxygen [Partial pressure] in Venous blood

279

1663

1.76

16.08

4.6

3.0

4.76

4.58

kpa

0.67

267

1608

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2357

21829

1.66

16.03

5.6

4.6

6.23

5.98

mmol/l

11.23

2135

19871

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

299

1826

1.72

15.80

5.4

4.0

1.22

1.23

mmol/l

0.45

259

1584

(3000475) Leukocytes [#/volume] in Synovial fluid

123

554

2.28

15.78

1.7

1.6

12576.62

12624.24

e6/l

0.00

395

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

342

2172

1.66

15.59

2.4

2.2

0.21

g/l

0.99

320

2033

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

209

1153

1.88

15.52

2.6

2.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

157

785

2.06

15.48

1.3

1.2

1.65

0.94

u/ml

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

136

647

2.16

15.27

1.6

—

(3045424) Erythrocytes [Presence] in Urine

375

2.53

15.25

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

228

1301

1.82

15.21

2.6

1.9

1.65

1.43

g/l

0.29

202

1185

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2522

23867

1.95

15.17

14.5

10.6

27.19

26.94

u/l

0.24

2432

23005

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

131

624

2.16

14.67

1.3

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

4.48

14.48

1.8

1.4

—

(40767503) Oxygen content in Capillary blood by calculation

111

497

2.29

14.46

2.8

2.6

15.67

16.09

0.48

258

(1616796) Gas panel - Central venous blood

113

510

2.27

14.45

4.0

4.1

—

(3010421) pH of Blood

128

609

2.16

14.38

4.5

4.6

7.42

0.17

116

553

(3023183) Ammonium ion [Moles/volume] in Plasma

107

474

2.31

14.29

2.0

2.9

29.67

36.85

umol/l

3.83

102

430

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

378

2512

1.59

14.27

2.8

2.7

9.00

8.42

umol/l

0.11

317

2216

(3000991) Gas panel - Venous blood

298

1871

1.67

14.15

9.4

9.0

—

(3012501) Base excess in Blood by calculation

113

515

2.25

14.12

4.6

4.9

2.50

2.66

mmol/l

0.26

358

(3013290) Carbon dioxide [Partial pressure] in Blood

113

516

2.24

14.06

4.6

5.0

5.18

5.05

kpa

0.97

108

510

(3027315) Oxygen [Partial pressure] in Blood

113

518

2.23

13.93

4.6

5.0

8.59

8.43

kpa

0.29

108

511

(3029937) Albumin [Presence] in Urine by Test strip

744

5704

1.42

13.90

5.3

3.9

0.00

estimate

0.03

283

1905

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

129

626

2.11

13.79

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

187

1037

1.86

13.66

1.8

1.64

1.54

g/l

0.72

158

901

(3045414) Leukocytes [Presence] in Urine

178

974

1.89

13.56

1.8

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

170

919

1.91

13.44

2.2

1.9

39.86

38.65

u/l

0.36

147

814

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

219

1281

1.77

13.43

1.5

—

(3000330) Specific gravity of Urine by Test strip

196

1112

1.82

13.31

4.5

3.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

118

562

2.15

13.24

5.3

4.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

269

2.68

13.24

2.1

2.3

30.60

19.94

mg/l

0.41

(3014111) Lactate [Moles/volume] in Serum or Plasma

308

1988

1.62

13.09

7.1

7.5

1.34

1.35

mmol/l

0.02

301

1947

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

125

614

2.09

12.96

1.4

1.5

0.24

g/l

0.23

114

584

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

123

3.54

12.93

1.2

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

114

544

2.14

12.74

3.2

3.9

—

(3017181) Myelocytes/100 leukocytes in Blood

298

1927

1.61

12.55

4.2

1.26

0.91

0.73

120

683

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

115

555

2.12

12.49

1.3

1.2

1.31

3.75

u/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

126

3.45

12.48

1.2

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

116

562

2.11

12.48

1.3

1.2

2.15

6.23

u/ml

1.49

(3004616) Nuclear Ab [Presence] in Serum

272

2.62

12.43

1.4

1.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

277

1765

1.63

12.38

4.0

0.89

0.67

0.57

112

590

(3006653) Thiamine [Moles/volume] in Blood

108

3.65

12.32

1.4

1.3

126.70

142.31

nmol/l

1.14

108

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

293

1901

1.61

12.16

2.3

7.98

7.51

ug/l

0.11

246

1685

(3021440) Promyelocytes/100 leukocytes in Blood

285

1837

1.62

12.15

4.2

0.10

0.12

0.13

107

592

(3033705) Calcium.ionized [Moles/volume] in Venous blood

252

2.66

12.15

2.8

2.6

—

(3037756) Immunofixation for Serum or Plasma

101

469

2.20

12.10

1.6

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2284

21318

1.48

11.53

20.5

13.5

79.74

79.95

ml/min/173m2

0.16

2011

17639

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

125

642

1.99

11.50

1.4

1.5

1.19

1.18

g/l

0.08

117

610

(3028626) Oxygen [Partial pressure] in Capillary blood

105

508

2.11

11.36

2.7

3.0

8.06

8.01

kpa

0.10

105

496

(3009542) Hematocrit [Volume Fraction] of Blood

2568

24690

1.94

11.09

34.8

21.1

39.48

40.49

4.31

2380

23119

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2367

22294

1.53

11.02

5.4

4.5

4.51

4.68

mmol/l

11.97

2163

20607

(46235355) HIV 1 and 2 tests - Meaningful Use set

408

2911

1.47

10.92

1.8

1.7

—

(3024731) MCV [Entitic volume]

2569

24717

1.93

10.85

34.6

20.9

91.51

91.24

2.11

2542

24337

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

138

3.15

10.84

1.9

2.4

530.22

568.07

e6/l

0.14

120

(3035941) MCH [Entitic mass]

2569

24719

1.93

10.82

34.6

20.8

30.39

0.06

2543

24340

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2287

21410

1.46

10.79

4.8

4.0

1.42

1.32

mmol/l

5.92

2072

19527

(3010813) Leukocytes [#/volume] in Blood

2569

24721

1.93

10.79

34.8

21.0

7.06

6.70

e9/l

10.18

2527

23994

(3026361) Erythrocytes [#/volume] in Blood

2569

24721

1.93

10.79

34.8

20.9

4.40

4.50

e12/l

19.12

2527

23992

(3007461) Platelets [#/volume] in Blood

2568

24710

1.92

10.76

34.8

21.0

253.82

248.40

e9/l

3.99

2532

24054

(3021901) Oxygen saturation in Capillary blood

426

2.18

10.72

2.6

2.9

—

(3000963) Hemoglobin [Mass/volume] in Blood

2569

24727

1.92

10.69

34.9

21.1

133.05

136.09

g/l

19.78

2542

24350

(3025159) Blasts/100 leukocytes in Blood

264

1731

1.58

10.46

4.3

0.11

0.43

0.69

489

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2349

22143

1.49

10.32

5.4

4.4

1.40

1.46

mmol/l

8.02

2139

20348

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

129

698

1.89

10.22

3.1

3.7

3.39

2.69

ratio

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

882

1.79

10.17

2.5

2.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

154

882

1.79

10.17

2.5

2.4

7.24

7.38

g/l

0.53

136

807

(3037121) Protein [Mass/volume] in Urine

140

780

1.84

10.12

3.4

0.59

0.30

g/l

1.41

336

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

362

2562

1.48

10.05

1.8

1.68

1.49

3.42

303

2252

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

199

1230

1.67

10.01

2.8

3.2

4.31

4.47

pmol/l

1.52

170

1087

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

272

2.42

9.96

1.7

1.5

54.77

58.17

0.27

170

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

153

882

1.78

9.89

2.5

2.4

3.49

3.68

g/l

0.60

135

807

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

100

3.43

9.87

1.3

1.0

0.99

1.12

u/l

0.91

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2396

22721

1.51

9.76

5.9

5.0

2.61

2.77

mmol/l

14.93

2182

20882

(3034860) Kappa light chains.free [Mass/volume] in Serum

130

717

1.85

9.72

3.3

3.7

44.35

65.21

mg/l

0.96

572

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

130

718

1.85

9.67

3.3

3.7

27.22

78.73

mg/l

1.84

575

(3005322) IgE [Units/volume] in Serum or Plasma

204

1284

1.64

9.56

1.4

1.3

268.13

202.43

u/ml

0.33

183

1183

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

104

536

1.98

9.53

1.6

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

137

774

1.81

9.48

3.1

2.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

381

2.16

9.47

3.9

3.6

1.65

1.44

0.22

336

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

3.70

9.43

1.2

1.1

358.20

626.73

ng/l

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

134

3.02

9.42

1.9

2.4

0.23

0.21

e9/l

0.40

119

(3011985) Renin [Units/volume] in Plasma

277

2.34

9.13

1.4

72.13

53.32

mu/l

0.47

248

(3023410) Appearance of Cerebral spinal fluid

182

2.67

9.04

2.3

1.3

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.10

8.98

1.1

1.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

312

2195

1.48

8.90

1.8

1.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

509

1.96

8.80

2.6

2.2

124.21

129.71

g/l

1.31

363

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

108

3.18

8.77

1.2

1.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

245

2.40

8.75

5.1

4.2

—

(3021788) Differential panel - Synovial fluid

407

2.07

8.74

1.6

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

141

824

1.75

8.73

2.4

8.99

10.39

g/l

5.45

122

746

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

110

3.12

8.52

1.2

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

825

1.74

8.43

2.6

2.4

2.67

2.97

g/l

3.66

122

751

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

427

2.02

8.40

1.2

52.30

49.67

u/ml

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

127

2.94

8.39

1.3

1.5

5.19

8.23

u/l

1.29

107

(3051593) INR in Capillary blood by Coagulation assay

3.64

8.28

19.3

17.8

—

(3017704) Immunofixation for Urine

134

2.86

8.22

1.3

1.7

—

(3004451) EKG impression Narrative

113

3.03

8.16

1.4

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

332

2.14

8.07

1.4

1.8

0.43

0.86

g/l

4.44

259

(3019150) Specific gravity of Urine by Refractometry

577

4580

1.33

8.03

4.5

3.8

1.02

kg/l

0.54

115

661

(40768804) Tissue Pathology biopsy report

1059

9118

1.27

7.87

2.2

2.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

100

3.12

7.83

2.7

2.5

—

(3025941) Bacteria identified in Stool by Culture

183

1180

1.59

7.80

1.3

1.2

—

(3022145) Colonoscopy Study observation

345

2534

1.41

7.79

1.3

—

(3044941) Cell count panel - Synovial fluid

365

2.06

7.72

1.5

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.36

7.65

2.3

3.1

86.80

161.70

umol/l

0.83

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

265

1865

1.47

7.53

3.7

2.7

145.01

195.82

ng/l

1.95

251

1696

(3040151) Glucose [Moles/volume] in Capillary blood

244

2.28

7.48

3.7

6.1

7.08

7.36

mmol/l

0.33

206

(3044927) Protein electrophoresis panel - Urine

238

2.29

7.46

1.1

1.2

—

(3021589) Normoblasts [#/volume] in Blood

1130

9847

1.25

7.45

14.6

9.7

0.00

e9/l

0.60

992

8027

(3003694) ABO and Rh group [Type] in Blood

725

6002

1.28

7.30

1.4

1.3

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

228

2.31

7.27

3.6

3.4

61.56

56.12

1.02

192

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

280

2.17

7.24

1.2

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

133

807

1.68

7.24

1.1

—

1.41

u/ml

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

267

2.20

7.23

1.3

1.4

323.33

326.14

pmol/l

0.02

233

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

356

2.02

7.11

1.3

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

736

6127

1.28

7.05

1.8

1.6

1.48

1.39

mmol/l

1.61

610

5114

(3000012) Reticulocyte production index

330

2.06

7.04

2.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

456

1.89

7.01

6.1

5.3

501.00

671.73

iu/ml

0.21

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1439

12939

1.24

6.99

3.0

2.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

479

1.87

6.94

1.3

1.4

—

(3038026) Centromere Ab [Units/volume] in Serum

189

2.40

6.94

1.3

1.1

—

54.98

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.01

6.92

1.7

1.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.01

6.92

1.7

1.9

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

3.12

6.86

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

103

2.93

6.85

1.1

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

103

2.93

6.85

1.1

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

994

8604

1.25

6.77

4.8

4.9

2.19

2.85

ug/l

1.75

897

7721

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

115

2.80

6.74

1.1

—

(21494755) Public health laboratory ask at order entry panel

114

1851

0.60

6.72

1.3

1.4

—

(3004775) Volume in Urine collected for unspecified duration

192

2.37

6.72

2.5

2.2

619.87

636.48

0.08

123

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.95

6.69

1.7

1.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

104

603

1.75

6.69

4.0

3.0

1.70

1.57

mg/l

0.65

552

(3011412) CD3 cells [#/volume] in Blood

206

2.30

6.61

2.0

2.3

1.26

1.16

e9/l

0.31

190

(3042733) HLA Ab [Presence] in Serum

3.35

6.55

6.1

5.4

—

(3036489) Thrombin time

123

755

1.66

6.44

2.7

1.9

21.03

21.72

0.69

110

668

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

3.14

6.44

2.8

2.2

159751.17

32074.36

u/ml

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

121

740

1.67

6.42

4.0

2.9

0.34

0.33

u/ml

0.27

413

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

160

2.46

6.35

1.5

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

457

1.84

6.35

1.6

1.3

12.25

9.80

u/l

0.74

367

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

414

1.89

6.34

1.7

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

3.01

6.22

1.1

—

(3024928) Oxygen saturation in Venous blood

475

1.82

6.21

4.9

2.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

543

1.76

6.15

1.7

1.6

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.30

6.13

2.1

2.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

246

2.14

6.12

1.3

1.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

501

1.78

6.05

4.4

1.8

0.90

0.85

nmol/l

0.24

414

(3010144) Erythrocytes [#/volume] in Synovial fluid

221

2.19

6.04

1.4

1.3

26432.12

55165.22

e6/l

0.44

160

(4200892) Spirometry reversibility

228

1628

1.44

6.02

1.4

—

(3014271) Vancomycin [Susceptibility]

111

2.72

6.02

3.4

2.7

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.35

5.99

1.3

1.4

70.71

181.87

nmol/24h

0.56

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

123

2.62

5.97

1.6

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

123

2.62

5.97

1.6

1.8

—

(3008898) HLA-B27 [Presence]

110

670

1.67

5.96

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

249

2.11

5.94

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

587

1.71

5.92

2.6

2.2

197.73

113.71

ug/min

0.50

356

(3010838) Calcium [Moles/time] in 24 hour Urine

395

1.87

5.92

1.8

1.9

4.47

5.02

mmol/24h

0.74

341

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

558

1.73

5.88

2.1

2.0

10.80

11.77

mg/l

0.43

514

(40761539) Cells [Type] in Urine sediment by Light microscopy

3.54

5.88

1.2

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

122

767

1.62

5.84

2.6

2.5

0.57

1.24

g/l

1.44

102

668

(3022621) pH of Urine by Test strip

199

1394

1.46

5.82

3.2

3.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

365

2835

1.33

5.78

6.9

6.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

186

1289

1.48

5.75

1.2

137.23

165.81

iu/ml

0.37

473

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

562

1.72

5.74

1.7

1.6

—

(3044889) 12 lead EKG panel

1733

16057

1.22

5.73

4.6

3.8

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

321

2453

1.35

5.67

1.8

1.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

176

2.29

5.62

1.3

1.1

—

4.63

—

(4146454) Self-monitoring of blood glucose

269

2.03

5.58

2.6

2.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

140

2.45

5.54

1.9

1.6

6.72

6.75

u/l

0.00

121

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

397

1.84

5.53

1.3

1.2

—

(3049717) Cytology report of Urine Cyto stain

137

900

1.55

5.47

2.4

2.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

3.48

5.45

1.6

1.4

0.60

0.38

ug/l

0.69

(4062490) Immunoglobulin typing, IgG

198

2.19

5.44

1.3

1.5

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

265

2.02

5.43

1.2

1.3

—

nmol/l

—

(40761535) Cells panel - Urine sediment

249

1840

1.39

5.43

3.7

3.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

234

2.07

5.27

1.6

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

104

646

1.63

5.26

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

283

1.96

5.22

1.3

1.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

555

1.68

5.21

1.3

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

3.14

5.19

1.7

1.5

13.26

15.92

pmol/l

0.76

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

4.59

5.17

1.4

1.5

79.44

138.67

ng/l

1.60

(3027135) IgG subclass 1 [Mass/volume] in Serum

196

2.16

5.16

1.3

1.5

5.52

6.71

g/l

1.47

140

(3028192) IgG subclass 2 [Mass/volume] in Serum

196

2.16

5.16

1.3

1.5

2.49

2.94

g/l

1.09

139

(3024139) IgG subclass 3 [Mass/volume] in Serum

196

2.16

5.16

1.3

1.5

0.42

0.37

g/l

0.34

138

(3020891) Body temperature

134

888

1.54

5.16

5.2

4.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

4.86

5.11

5.3

4.6

—

(3028707) Methadone [Presence] in Urine by Screen method

204

2.13

5.08

1.9

2.4

—

(3003181) Sodium [Moles/volume] in Urine

379

1.81

5.07

1.4

62.31

60.70

mmol/l

0.12

304

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

279

1.95

5.07

1.3

1.4

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

128

2.44

5.04

1.2

1.4

—

545.45

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

116

2.52

5.04

1.7

1.6

1.96

1.98

u/field

0.01

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

109

694

1.59

5.00

2.2

38.44

37.76

g/l

0.66

619

(3052851) Hemolysis interference index of Serum or Plasma

104

655

1.61

4.99

3.9

3.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

282

1.93

4.93

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

275

1.95

4.93

1.3

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

275

1.95

4.93

1.3

1.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

457

1.73

4.93

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

457

1.73

4.93

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

277

1.93

4.83

1.3

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

496

4101

1.26

4.83

2.9

3.1

2.45

mmol/l

0.31

436

3612

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

118

773

1.55

4.81

1.5

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

394

1.77

4.77

3.8

3.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

6.49

4.77

1.6

1.0

—

(3042631) Mycobacterium sp identified in Specimen

322

1.85

4.73

2.4

2.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

164

2.21

4.72

1.3

1.5

1.25

1.27

promille

0.03

126

(3020876) Protein [Mass/time] in 24 hour Urine

266

1.94

4.69

2.3

1.35

1.43

g/24h

0.05

130

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

179

1283

1.42

4.68

1.9

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.50

4.61

1.2

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

101

647

1.58

4.55

3.0

2.0

96.54

90.91

1.73

625

(3016244) Insulin [Units/volume] in Serum or Plasma

104

2.51

4.54

2.7

3.2

30.93

22.42

mu/l

0.44

(3006270) Folate [Moles/volume] in Blood

180

2.13

4.54

1.2

301.19

379.07

nmol/l

1.38

157

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

273

2109

1.33

4.50

3.6

2.4

32.10

59.92

u/l

0.66

233

1823

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.39

4.43

8.9

12.3

4.51

5.67

mmol/l

1.19

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

620

1.59

4.42

3.6

2.3

3.65

3.62

g/l

0.06

587

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.63

4.39

1.2

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

144

2.24

4.34

1.2

—

(40758558) Short blood count panel - Blood

657

5658

1.21

4.33

7.4

6.9

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

101

2.49

4.29

1.5

1.1

3.17

5.20

iu/ml

—

(3028433) Virus identified in Specimen by Culture

2.79

4.28

1.1

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

3.05

4.24

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

192

1419

1.38

4.23

1.5

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

365

1.74

4.19

1.1

20.19

68.57

iu/ml

0.89

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

387

3162

1.26

4.15

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

316

1.79

4.08

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

258

1.88

4.08

1.5

1.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

8.02

4.06

1.3

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

369

1.72

4.05

1.3

1.2

300.34

268.08

u/ml

0.33

220

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.94

4.01

1.0

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

378

1.71

3.99

1.4

1.2

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

5.57

3.97

1.0

1.1

—

15.86

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

448

1.65

3.95

4.6

3.7

60.07

57.93

0.87

448

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

134

1872

0.70

3.93

1.7

1.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

191

1430

1.36

3.90

2.0

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

536

1.59

3.89

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

592

1.56

3.88

3.8

2.3

205.08

192.42

0.64

563

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

101

673

1.52

3.87

2.3

0.00

0.02

g/l

1.09

620

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

303

2426

1.28

3.85

3.2

4.3

105.88

23.89

ug/l

0.43

256

1990

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

236

1.88

3.79

1.2

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

564

1.56

3.78

1.5

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

564

1.56

3.78

2.7

2.5

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

208

1.94

3.77

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.60

3.74

2.1

2.8

0.82

0.46

u/field

0.41

(3011397) Hemoglobin [Presence] in Urine by Test strip

579

4995

1.20

3.69

4.1

3.4

—

(3020491) Glucose [Moles/volume] in Blood

149

2.09

3.63

1.6

1.9

6.83

6.94

mmol/l

0.08

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

546

1.56

3.62

1.3

—

(40768443) Skin Pathology biopsy report

137

984

1.41

3.61

1.3

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

212

1.90

3.58

1.2

1.5

28.27

31.76

0.24

132

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

653

1.50

3.57

1.5

1.26

10.66

iu/ml

0.49

128

(3011288) Drugs identified in Urine by Screen method

315

1.73

3.56

1.7

2.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

407

1.64

3.54

1.7

1.5

—

(3008295) Osmolality of Serum or Plasma

228

1.86

3.51

1.2

1.3

283.68

276.72

mosm/kgh2o

1.07

173

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

3.88

3.49

1.0

1.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

2.62

3.47

1.4

1.2

42.60

38.03

g/l

1.09

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.54

3.46

2.7

2.8

28.29

29.07

umol/l

0.10

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1235

0.66

3.43

1.4

1.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

419

1.61

3.42

1.7

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

373

1.65

3.40

1.7

1.4

121.00

119.85

u/ml

0.03

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

195

1.91

3.39

1.5

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.11

3.37

1.0

1.2

0.56

0.72

umol/24h

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

336

1.68

3.35

1.6

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

337

1.68

3.32

2.3

1.9

73.42

1688.70

u/l

—

123

(3048879) Bone marrow aspiration report

2.72

3.32

1.6

2.0

—

(3000060) B lymphocytes [#/volume] in Blood

2.93

3.30

1.5

2.3

90.00

156.67

e6/l

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

102

2.27

3.29

1.7

2.6

1019.30

1290.85

u/ml

0.29

102

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

3.65

3.29

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

3.65

3.29

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

378

1.63

3.24

1.7

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.39

3.22

1.1

1.0

—

(3023419) Bacteria identified in Sputum by Culture

348

1.65

3.21

4.0

2.6

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.54

3.19

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

2.87

3.19

1.9

2.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

637

1.48

3.18

2.3

0.00

g/l

-0.00

586

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

358

1.63

3.14

1.5

1.4

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.55

3.12

1.2

1.1

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

2.55

3.12

2.0

2.6

1.22

1.15

ug/l

0.04

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

131

2.07

3.12

1.0

836.50

728.73

ng/l

0.58

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

131

2.07

3.12

1.0

35.99

44.75

ng/l

0.60

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

187

1.88

3.10

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

152

1.98

3.09

1.1

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

222

1760

1.28

3.08

2.5

2.2

12.86

13.00

nmol/l

0.08

195

1567

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

231

1.79

3.08

1.8

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

261

1.74

3.07

1.7

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.69

3.05

1.3

1.1

305.88

259.15

pmol/l

—

(3002385) Erythrocyte distribution width [Ratio]

1994

19120

1.17

3.05

26.8

17.0

16.12

15.06

8.57

1979

18744

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.59

3.04

1.3

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.51

3.04

1.2

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

185

1438

1.31

2.99

1.2

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

630

1.46

2.97

2.3

0.00

g/l

-0.00

585

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

326

1.64

2.93

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

374

1.59

2.90

1.8

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

374

1.59

2.90

1.8

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

305

0.39

2.87

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

512

1.50

2.85

2.1

1.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

100

712

1.42

2.83

1.6

1.4

24.46

31.86

iu/l

1.70

610

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.20

2.83

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

2.23

2.80

1.9

2.5

57.60

50.49

umol/l

0.37

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.92

2.77

1.2

1.0

—

(3012898) Urea [Moles/volume] in Urine

3.92

2.77

1.1

1.3

225.56

151.22

mmol/l

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

8.35

2.75

1.2

1.7

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

138

1.97

2.75

1.1

1.2

—

(3016750) Collection duration of Urine

145

1.94

2.75

2.5

2.0

528.16

488.67

min

0.88

104

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

5.01

2.73

1.0

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

132

1.98

2.70

1.1

1.0

371.53

324.74

ng/l

0.17

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

334

1.60

2.69

1.7

1.6

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.18

2.67

1.5

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

140

1.94

2.65

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

621

1.43

2.64

1.4

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

597

1.44

2.61

1.1

1.2

64.29

94.58

titre

—

(40768446) Kidney Pathology biopsy report

2.16

2.60

1.9

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

128

1.96

2.55

1.5

1.2

18.35

21.78

u/l

0.28

109

(3027923) C peptide [Moles/volume] in Serum or Plasma

128

1.96

2.55

1.3

1.4

1.10

1.22

nmol/l

0.20

101

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.74

2.54

1.4

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

626

1.42

2.54

1.4

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.51

2.53

1.1

1.4

89.63

87.55

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.23

2.51

1.7

1.4

—

(3024932) HLA-DR beta [Type]

2.27

2.51

1.1

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

209

1.73

2.50

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

209

1.73

2.50

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

209

1.73

2.50

1.6

—

(3052592) Norovirus Ag [Presence] in Stool

2.98

2.48

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

512

1.46

2.48

1.6

1.7

291.71

296.84

mu/l

0.04

473

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.47

2.48

1.8

2.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.47

2.48

1.8

2.4

—

(3025577) Chromium [Mass/volume] in Blood

151

1.86

2.47

2.3

2.0

1.83

2.14

ug/l

0.29

131

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.82

2.46

1.0

1.3

7.75

15.00

u/l

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.39

2.46

1.3

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

2.39

2.46

1.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

2.14

2.44

1.1

1.2

194.47

173.81

mmol/24h

0.41

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.13

2.43

1.4

2.2

17.59

18.51

umol/l

—

(3051611) Lipemic interference index of Serum or Plasma

219

1.70

2.41

4.1

3.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

617

1.41

2.38

1.4

1.1

—

(3024471) HLA-A [Type]

2.22

2.37

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

539

0.59

2.36

1.7

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

3.64

2.36

1.3

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

183

1.76

2.35

1.9

2.2

3.25

1.84

u/field

0.48

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.04

2.35

1.2

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

147

1.85

2.33

1.9

2.8

38.92

40.95

0.19

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.19

2.31

1.2

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

155

1.81

2.29

1.2

1.3

0.22

1.00

u/ml

1.21

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.07

2.27

2.3

2.8

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

3.49

2.27

1.3

1.1

—

(3016879) Cocaine [Presence] in Urine

456

1.46

2.25

1.6

2.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

113

1.95

2.25

1.1

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

247

1.63

2.25

1.7

1.9

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

135

1.86

2.22

1.5

1.2

72.75

83.50

u/l

0.42

117

(3002619) Bacteria identified in Specimen by Culture

2.86

2.20

1.8

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

150

1.81

2.20

2.1

2.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

369

1.50

2.18

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

158

1.78

2.17

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

158

1.78

2.17

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

496

1.42

2.11

1.5

1.8

2.72

5.09

iu/l

3.13

168

(44816559) Phosphatidylethanol [Mass/volume] in Blood

364

1.49

2.10

1.4

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1.76

2.09

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1.76

2.09

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

160

1.76

2.09

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

2.26

2.07

1.4

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

269

1.57

2.06

1.2

1.0

3.60

2.47

u/ml

—

116

(3043409) Potassium [Moles/volume] in Arterial blood

678

1.35

2.05

4.9

4.0

3.95

3.89

mmol/l

0.47

672

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.33

2.04

1.2

1.1

96.29

88.86

—

(40757373) Influenza virus identified in Isolate

2.51

2.01

1.5

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.23

2.01

1.2

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

2.01

2.00

4.6

4.2

47.15

64.58

mg/l

0.82

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.95

1.2

1.3

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.97

1.93

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.97

1.93

1.4

1.5

—

(3000764) Benzodiazepines [Presence] in Urine

490

1.40

1.90

1.6

1.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

158

1.72

1.89

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

553

0.65

1.87

1.1

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

197

1.63

1.86

1.8

1.6

—

(3023511) Choriogonadotropin [Units/volume] in Urine

174

1.67

1.86

1.2

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.17

1.82

17.4

10.9

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

168

1.67

1.80

1.1

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

329

1.47

1.77

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

3.34

1.74

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

3.34

1.74

1.2

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

201

1.60

1.74

1.3

1.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

209

1.59

1.74

1.3

1.1

—

(3027008) Opiates [Presence] in Urine

491

1.37

1.72

1.6

1.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.92

1.72

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

2.92

1.72

1.3

2.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.85

1.71

1.4

4.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

2.14

1.71

1.5

1.3

11.26

8.77

ug/l

0.72

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

2.30

1.70

2.9

2.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

164

1.65

1.68

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.19

1.67

1.7

1.6

—

(3028300) Cannabinoids [Presence] in Urine

494

1.37

1.67

1.7

1.9

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

2.80

1.65

2.3

1.9

—

(44813793) Dust mix specific IgE antibody measurement

127

1.74

1.64

1.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

646

1.31

1.59

2.2

1.8

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

121

1.74

1.58

1.6

1.8

8.06

12.11

umol/l

0.31

(3050129) First trimester maternal screen panel - Serum or Plasma

209

0.48

1.58

1.4

1.5

—

(3001186) Copper [Moles/volume] in Serum or Plasma

2.20

1.57

1.6

1.2

15.50

16.59

umol/l

0.26

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

364

1.41

1.55

1.1

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

998

0.76

1.54

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.04

1.54

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

485

1.35

1.52

1.6

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

225

1.52

1.51

1.2

1.4

—

27.75

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

209

1.54

1.51

2.5

2.4

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

521

1.33

1.50

2.7

3.5

829.95

888.14

u/ml

0.03

485

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

185

0.48

1.50

1.6

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.95

1.48

1.2

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

202

1.54

1.48

1.2

1.3

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

292

1.45

1.48

1.1

128.74

115.97

1.53

267

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

219

1.51

1.46

1.3

1.4

0.25

0.30

nmol/l

0.25

165

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

524

1.33

1.45

1.8

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

1.45

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

102

1.77

1.44

1.0

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

236

1.49

1.44

3.0

3.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.13

1.44

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.73

1.43

1.8

2.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.73

1.43

1.7

1.5

53.17

45.77

umol/l

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.04

1.43

5.8

7.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

165

1.58

1.40

1.7

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

178

0.50

1.39

1.3

1.4

91.10

215.84

pmol/l

—

178

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.61

1.36

6.3

3.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

464

5070

0.90

1.34

3.0

0.66

0.75

ug/l

2.04

318

3389

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.97

1.32

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

1.81

1.31

1.9

2.3

152.80

163.13

0.17

(3043238) Trisomy 21 risk [Likelihood] in Fetus

150

0.47

1.31

1.4

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.10

1.30

1.1

—

(4035726) Immunohistochemistry procedure

239

2098

1.15

1.29

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

172

0.52

1.29

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

172

0.52

1.29

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

172

0.52

1.29

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

172

0.52

1.29

1.3

1.4

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

145

1.59

1.29

1.2

—

(3019174) dRVVT (LA screen)

2.78

1.28

1.0

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.78

1.28

1.4

—

(3051651) Icteric interference index of Serum or Plasma

130

1.62

1.26

3.0

3.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

123

1023

1.21

1.26

1.0

—

(3047189) Immunofixation for 24 hour Urine

115

1.66

1.24

1.4

1.5

—

(4094501) Cardiovascular stress test using bicycle ergometer

654

1.26

1.24

1.2

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

100

1.70

1.23

1.2

0.99

1.04

ratio

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.91

1.22

1.9

2.5

212.08

175.52

0.25

(3036180) Methadone [Presence] in Urine

1.91

1.22

1.3

1.8

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.91

1.22

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.04

1.22

2.4

2.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.63

1.21

1.0

1.2

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.72

1.21

1.4

1.1

332.31

214.25

iu/ml

0.30

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.80

1.21

1.0

1.1

1383.93

1595.82

miu/ml

0.26

(3047352) Trisomy 18 risk [Likelihood] in Fetus

145

0.48

1.19

1.4

—

(3005033) Fetal Nuchal fold Thickness US

145

0.48

1.19

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.31

1.18

1.0

1.2

1.76

1.87

umol/24h

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

257

2288

1.14

1.16

1.5

—

(3005570) Glucose [Moles/volume] in Urine

215

1.45

1.16

2.2

2.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

500

1.29

1.15

5.4

3.3

33.29

26.17

mg/l

0.44

311

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

2.05

1.15

7.0

6.4

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

2.50

1.15

8.8

11.8

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.50

1.15

1.4

1.2

76.00

103.33

ug/l

—

(3006462) Nitrate [Presence] in Urine

1.69

1.13

4.8

3.5

—

(4281824) Cell count and differential, peritoneal fluid

232

0.60

1.10

1.1

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

160

1.50

1.09

1.3

1.5

92.58

83.35

umol/l

0.36

160

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.38

1.09

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.95

1.08

1.0

1.2

—

(3023383) Lactate [Moles/volume] in Pleural fluid

1.76

1.06

1.2

1.4

3.48

3.34

mmol/l

0.06

(3042111) Morphology [Interpretation] in Bone marrow Narrative

418

1.30

1.06

1.8

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

145

1.52

1.06

1.3

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

129

1.55

1.05

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

129

1.55

1.05

1.1

1.0

—

(3045788) Cell count panel - Pleural fluid

228

0.61

1.04

1.9

1.5

—

(3020393) Adenovirus Ag [Presence] in Stool

2.28

1.03

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.28

1.03

1.4

2.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.89

1.01

1.3

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.77

1.00

1.4

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

132

0.53

0.98

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.84

0.98

1.6

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

378

0.71

0.98

3.0

3.7

29.79

34.13

u/ml

0.13

365

(3024263) Appearance of Synovial fluid

124

1.54

0.96

1.5

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.86

0.96

6.0

7.3

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.95

0.0

1.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

117

0.51

0.94

13.8

13.3

1041.33

857.19

nmol/l

—

110

(3003338) MCHC [Mass/volume]

1821

18606

0.93

0.92

28.3

18.3

332.09

332.49

g/l

1.03

1812

18465

(3009466) Valproate [Moles/volume] in Serum or Plasma

296

1.32

0.91

4.1

5.5

339.55

366.94

umol/l

0.54

260

(3036071) Salmonella sp Ab [Titer] in Serum

1.69

0.88

1.5

1.0

—

(4034850) Laboratory test

721

1.20

0.88

12.6

9.3

—

(21494434) Karyotype in Bone marrow

220

1.37

0.87

1.4

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.86

0.87

1.0

1.2

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

136

1.47

0.86

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

334

1.29

0.86

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.76

0.83

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.76

0.83

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.76

0.83

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

1.76

0.83

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

105

1.53

0.81

1.0

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

302

1.30

0.81

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.70

0.80

1.6

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

215

1.35

0.80

3.5

3.1

17.08

35.89

mg/l

0.99

161

(3034426) Prothrombin time (PT)

1.67

0.78

1.3

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.77

0.0

1.0

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

296

1.29

0.76

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

323

1.27

0.76

1.2

1.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.70

0.75

2.4

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

306

1.28

0.75

1.4

1.2

2.60

4.32

u/ml

0.99

130

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.09

0.74

1.0

1.5

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.09

0.74

1.0

1.5

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.09

0.74

1.0

1.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

308

1.27

0.72

1.4

1.2

8.64

4.26

u/ml

0.38

102

(3044242) Glucose [Moles/volume] in Arterial blood

117

1.46

0.71

1.6

2.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

109

1.47

0.71

1.4

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

143

1.40

0.70

1.8

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

143

1.40

0.70

1.8

1.7

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.55

0.69

1.6

1.4

40.11

26.87

—

(3019832) Treponema pallidum Ab [Presence] in Serum

124

1098

1.14

0.68

1.5

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.67

0.68

1.0

1.3

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.60

0.68

2.1

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.60

0.68

2.1

2.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.53

0.68

1.1

—

(3020650) Glucose [Presence] in Urine

1.53

0.68

1.1

1.7

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

110

1.46

0.68

3.9

4.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

127

1.42

0.68

1.3

1.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.63

0.66

1.0

1.8

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

303

1.26

0.66

1.7

2.3

16498.00

95.78

u/ml

0.49

295

(3028717) Thiamine [Mass/volume] in Blood

1.79

0.66

1.2

1.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.59

0.65

3.7

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.63

0.62

1.0

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

115

1023

1.13

0.61

2.7

3.7

51.29

65.21

u/ml

0.36

110

988

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

8.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

717

6892

1.06

0.60

4.2

21.52

21.57

0.03

333

3352

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.60

0.0

6.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.60

0.0

3.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.48

0.57

2.2

2.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

196

1.28

0.52

1.3

1.2

—

(3025130) Human papilloma virus identified in Specimen

214

1.26

0.52

2.0

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

425

1.18

0.51

3.3

3.2

0.76

0.82

nmol/l

0.49

326

(3017569) Oxygen content in Arterial blood

109

1.38

0.51

1.5

2.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.56

0.49

1.4

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

290

1.21

0.47

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

200

1863

1.08

0.47

2.5

2.6

63.76

65.37

ml/min/173m2

0.18

722

(1002224) Polysomnography panel

892

1.11

0.46

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

113

1.33

0.42

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.56

0.42

1.4

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.56

0.42

1.8

1.5

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.52

0.41

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.52

0.41

1.4

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

548

1.13

0.41

1.3

1.1

—

(3042517) Benzodiazepines panel - Urine

0.00

0.41

0.0

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.43

0.39

2.0

1.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.39

0.0

1.3

—

(3000285) Sodium [Moles/volume] in Blood

1.35

0.37

1.6

1.1

—

(3002256) Pathology report gross observation

316

3019

1.05

0.37

1.4

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.29

0.36

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

189

1.22

0.36

1.1

—

(1761868) Lipid panel - Serum or Plasma

774

7936

0.97

0.35

3.7

2.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

861

1.10

0.35

2.6

3.5

46.37

2736.83

u/ml

1.21

730

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

217

1.20

0.35

2.7

2.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

124

0.72

0.35

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.40

0.35

1.0

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

145

1.24

0.33

1.3

1.57

1.56

g/l

0.09

145

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

407

1.13

0.32

1.2

53.05

42.69

u/l

0.21

345

(3000492) Spirometry study

234

2233

1.05

0.30

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.27

0.30

1.4

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

282

0.85

0.29

1.1

0.25

1.78

u/ml

—

115

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

525

1.11

0.29

1.3

1.2

178.86

202.55

miu/ml

0.24

223

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

112

1.25

0.28

1.0

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

291

0.86

0.28

1.1

1.89

4.47

u/ml

1.20

141

(3045142) Bone marrow Pathology biopsy report

280

1.14

0.27

1.8

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

252

1.15

0.27

1.7

1.4

235463.06

95004.80

e6/l

0.62

152

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

1.23

0.27

1.6

1.9

8.03

8.95

mg/l

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.68

0.26

1.6

2.3

162.80

151.31

nmol/l

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

329

1.13

0.26

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

169

1.18

0.25

1.3

1.5

0.92

0.97

g/l

0.36

169

(3010726) Horse dander IgE Ab [Units/volume] in Serum

266

0.86

0.25

1.2

1.1

0.73

1.46

u/ml

—

133

(3035320) C reactive protein [Mass/volume] in Body fluid

133

1.20

0.24

2.3

2.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.76

0.22

1.0

1.1

—

0.44

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

153

1.18

0.22

1.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

0.21

0.0

1.1

—

7.71

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.21

0.0

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.6

—

1.33

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

21.62

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

8.08

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

38.42

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

117

1.20

0.20

1.4

1.7

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

117

1.20

0.20

1.4

1.7

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

0.00

0.20

0.0

2.0

—

(3015183) Erythrocyte sedimentation rate

113

0.80

0.20

1.1

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

1.20

0.19

1.0

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

185

0.86

0.18

1.0

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.15

0.17

1.9

1.6

—

(40768806) Pleura Pathology biopsy report

247

0.89

0.17

2.1

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

253

1.11

0.17

1.9

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

253

1.11

0.17

1.9

1.5

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

273

1.10

0.16

2.3

3.5

12.95

26.07

nmol/l

0.27

268

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.10

0.15

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

626

0.94

0.15

1.3

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

171

1.11

0.12

1.4

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

137

0.88

0.12

3.3

6.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

160

1639

0.97

0.10

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

289

0.93

0.09

1.0

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

206

0.92

0.08

1.1

12.69

3.30

u/ml

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.09

0.08

1.1

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.06

0.08

1.1

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

244

1.07

0.08

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

652

0.97

0.07

1.7

1.8

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.05

0.07

2.6

2.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

103

1006

1.02

0.07

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

288

2847

1.01

0.06

1.4

—

(3035880) pH of Pleural fluid

129

1.09

0.05

1.8

1.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

129

1.09

0.05

1.2

1.1

—

(40768793) Breast Pathology biopsy report

485

1.03

0.05

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

303

0.96

0.05

1.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

302

0.96

0.04

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

220

0.95

0.03

1.1

3.37

2.44

u/ml

—

(3012441) Differential panel - Pleural fluid

248

0.97

0.02

2.0

1.5

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

103

1.07

0.02

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

117

0.94

0.01

4.1

3.7

—

(40768441) Liver Pathology biopsy report

156

0.96

0.00

1.1

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

159

1.01

0.00

1.6

1.3

14.56

11.94

u/l

0.33

146

(40768795) Lymph node Pathology biopsy report

229

1.00

0.00

1.0

1.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

334

0.99

0.00

1.2

1.1

0.25

1.70

u/ml

3.62

174

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

586

1.01

0.00

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

774

0.99

0.00

1.7

3.72

4.19

mg/l

0.18

570

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

593

0.99

0.00

1.2

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

1.03

0.00

16.4

11.7

0.61

0.62

mmol/l

—

(3036782) Glucose [Moles/volume] in Pleural fluid

217

1.01

0.00

1.9

1.5

6.49

6.47

mmol/l

0.01

202

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

249.71

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.2

—

174.40

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

5.4

—

1.10

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

-0.00

0.0

1.8

—

859.83

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

1.40

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

0.93

-0.00

1.0

1.1

—

(3016135) IgD [Mass/volume] in Serum

0.00

-0.00

0.0

1.3

—

120.79

—

(36303858) Crystals [Presence] in Urine

0.00

-0.00

0.0

1.0

—

(3044007) Cell count panel - Peritoneal fluid

0.94

-0.00

1.3

2.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

-0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

2.5

—

2.72

—

(3033799) Differential panel - Peritoneal fluid

0.96

-0.00

1.6

2.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

0.98

-0.00

2.7

2.1

—

(3035933) Granulocytes/100 leukocytes in Blood

0.89

-0.00

1.4

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.90

-0.00

1.8

3.3

5.12

7.31

mg/l

—

(40765096) Chromosome analysis panel by Banding

0.98

-0.00

1.3

1.1

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint G6_NEUROOTH and mortality.

Females

Parameter	HR [95% CI]	p-value
G6_NEUROOTH	1.537 [1.37, 1.72]	< 0.001
Birth year	0.994 [0.98, 1.0]	0.136

During the follow-up period (1.1.1998 — 31.12.2019), 1028 out of 5356 females with G6_NEUROOTH died.

Males

Parameter	HR [95% CI]	p-value
G6_NEUROOTH	1.566 [1.4, 1.75]	< 0.001
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1427 out of 6181 males with G6_NEUROOTH died.

Mortality risk

Mortality risk for people of age

years, who have G6_NEUROOTH.

N-year risk	Females	Males
1	0.143%	0.305%
5	0.884%	1.664%
10	2.071%	4.471%
15	4.006%	8.346%
20	6.955%	13.924%

Relationships between endpoints

↥

Index endpoint: G6_NEUROOTH – Other disorders of nervous system

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other disorders of nervous system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints